<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>ALE Week14 by Hoang Le</title>
      <link>https://padlet.com/hoangle/ale</link>
      <description>Hello! Padlet ALE is a semester-long project. You will expand your post-it entry on every Wednesday ALE that you have lectures with me. For this week, do the following tasks: 1) Do literature search on your assigned drug; 2) Report the role of the drug in interaction with the target (e.g., agonist, antagonist, inverse agonist, enzyme inhibitor, enzyme inactivator, etc.) If the target is unknown, say that the role is unknown; 3) Report the indication of the drug (the use of the drug for treating a particular disease); 4) Report the side effects of the drugs.</description>
      <language>en-us</language>
      <pubDate>2019-08-29 01:01:05 UTC</pubDate>
      <lastBuildDate>2022-11-28 00:53:34 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Delancy Anderson </title>
         <author></author>
         <link>https://padlet.com/hoangle/ale/wish/2270250628</link>
         <description><![CDATA[<ul><li>Assigned Drug: Levothyroxine&nbsp;</li><li>Structure: (image attached)</li><li>Functional Groups: Phenolic –OH group (Ar-OH), halide (-I), ether (Ar-O-Ar), primary amine (-NH2) carboxylic acid (-COOH)&nbsp;</li><li>Heterocycles: ? (i will come back and edit)</li></ul><div><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1780415494/819b55c832dc3c6db62024a001c36fba/9A57671B_39A2_4111_A263_FBC24ABE2E9D.jpeg" />
         <pubDate>2022-08-24 15:28:42 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270250628</guid>
      </item>
      <item>
         <title>Erin Lomenick</title>
         <author>ErinLomenick</author>
         <link>https://padlet.com/hoangle/ale/wish/2270286280</link>
         <description><![CDATA[<div>Assigned Drug: monetlukast<br><br>Structure: image attached<br><br>Functional groups: tertiary alcohol, carboxylicic acid, benzene, thioester, halogen<br><br>Heterocycles: quinoline</div><div><br>Indication: allergic rhinitis, persistent asthma, exercise induced bronchoconstriction<br><br>Target: CysLT Type 1 Receptor<br><br>MOA: Selective leukotriene receptor antagonist that inhibits cysteinyl leukotriene receptor. Prevents airway edema and smooth muscle contraction<br><br>Role: Antagonist<br><br>Common side effects include: Gastrointestinal (abdominal pain, diarrhea), Neurologic (headache), Otic (otitis, otitis media), Respiratory (cough, nasal discharge, pharyngitis, sinusitis, upper respiratory infection), Other (fever, influenza)<br><br>Serious Side Effects: Cardiovascular (eosinophilic granulomatosis with polyangitis), Neurologic (disoriented, disturbance of attention, insomnia, memory impairment, stuttering, tic, tremor) Psychiatric (aggressive behavior, agitation, anxiety, depression, hallucinations, irritability, nightmares, Obsessive-compulsive disorder, restlessness, sleep walking disorder, suicidal behavior, suicidal thoughts)<br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774142771/42091bf5ddf56c02813532093f7526c2/Monetlukast_Strucutre.png" />
         <pubDate>2022-08-24 15:55:39 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270286280</guid>
      </item>
      <item>
         <title>Lexiana Walker</title>
         <author>luwalker</author>
         <link>https://padlet.com/hoangle/ale/wish/2270449260</link>
         <description><![CDATA[<div>Assigned Drug:Lovastatin<br>Structure: ^<br>Functional Groups: <strong>two ester functionalities with one being a lactone, a pair of conjugated carbon-carbon double bonds, and a hydroxyl group</strong>.<br>Heterocytes:....<br>Mechanism of Action: Lovastatin is metabolized into its active form beta-hydroxy acid in the stomach and functions to <strong>competitively inhibit 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase</strong></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286415/53bba0489af377624b0e79268dffb6cf/image.png" />
         <pubDate>2022-08-24 18:14:49 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270449260</guid>
      </item>
      <item>
         <title>Elise Crumrine </title>
         <author>evcrumri</author>
         <link>https://padlet.com/hoangle/ale/wish/2270455042</link>
         <description><![CDATA[<ul><li>Assigned drug - Propranolol&nbsp;</li><li>Structure - image attached&nbsp;</li><li>Functional groups - alkane, ether, naphthalene, secondary alcohol, secondary amine</li><li>Heterocycles - none&nbsp;</li><li>Indication - hypertension, tremors, ventricular arrhythmia, angina, myocardial infarction, migraine, etc.&nbsp;</li><li>Targets - nonselective beta-adrenergic blocker (class II antiarrhythmic)</li><li>MOA - competitively blocks response to beta<sub>1</sub>- and beta<sub>2</sub>-adrenergic stimulation which results in decreases in heart rate, myocardial contractility, blood pressure, and myocardial oxygen demand. Nonselective beta-adrenergic blockers reduce portal pressure by producing splanchnic vasoconstriction thereby reducing portal blood flow.</li><li>Antagonist&nbsp;</li><li>Side effects - Feeling dizzy, sleepy, tired, or weak, upset stomach or throwing up, stomach pain or cramps, diarrhea or constipation, trouble sleeping, strange or odd dreams</li></ul>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286082/c7ea6a9f56e4570e2cfa186106f1e74c/B5DFFBFA_2D89_4AF2_B18F_300B3CC80DF2.jpeg" />
         <pubDate>2022-08-24 18:20:00 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270455042</guid>
      </item>
      <item>
         <title>Adisyn Fleming</title>
         <author>akflemin</author>
         <link>https://padlet.com/hoangle/ale/wish/2270464675</link>
         <description><![CDATA[<div>Assigned Drug - Esomeprazole<br><br>Functional Groups - ether, amines<br><br>Heterocysts - imidazole&nbsp;<br><br>Indication - acid-reflux disorders&nbsp;<br><br>Targets - parietal cells of stomach H+/K+ ATPase pumps<br><br>MOA - irreversible binds to proton pumps inhibiting release of HCl into the stomach and altering stomach pH&nbsp;<br><br>Side Effects - headache, diarrhea, stomach pain, dizzy, sleepy, or cause blurred vision</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286191/03e8d08d95e75e7bed60c3f9610c937e/esomeprazole.png" />
         <pubDate>2022-08-24 18:27:56 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270464675</guid>
      </item>
      <item>
         <title>Caroline Rakonick</title>
         <author>carakoni</author>
         <link>https://padlet.com/hoangle/ale/wish/2270465866</link>
         <description><![CDATA[<div>Assigned drug: clonidine&nbsp;<br><br>Structure: image attached&nbsp;<br><br>Functional groups: secondary amine, halogenated benzene ring<br><br>Heterocycles: imidazoline<br><br>Indication: antihypertensive<br><br>Target: Alpha 2-adrenergic<br><br>Mechanism of Action: alpha2-adrenergic antagonist effect in the posterior hypothalamus and medulla<br><br>Role: Antagonist<br><br>Side Effects:&nbsp;</div><ul><li>Dry mouth.</li><li>•Constipation.</li><li>•Feeling dizzy, sleepy, tired, or weak.</li><li>•Headache.</li><li>•Upset stomach.</li><li><strong>Extended-release tablets:</strong></li><li>•Trouble sleeping.</li><li>•Bad dreams.</li><li>•Decreased appetite.</li><li>•Stomach pain.</li><li>•Feeling irritable.</li><li><strong>Skin patch:</strong></li><li>•Skin irritation.</li><li><strong>Epidural:</strong></li><li>•Sweating a lot.</li><li>•Throwing up.</li><li>•Ringing in ears.</li></ul>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1403336140/755425167ba3c4145649d008515d99e4/DE9373F1_163F_4B23_AE5F_28743386C2BF.png" />
         <pubDate>2022-08-24 18:28:42 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270465866</guid>
      </item>
      <item>
         <title>Raven Chatman</title>
         <author>ravennichellechatman</author>
         <link>https://padlet.com/hoangle/ale/wish/2270468623</link>
         <description><![CDATA[<div>Assigned Drug: Hydroxyzine<br><br>Structure: Image Attached<br><br>Functional Groups: nitrogen atoms substituted by 2-(2-hydroxyethoxy) ethyl and (4-chlorophenyl)(phenyl) methyl groups<br><br>Heterocycles: Heterocyclic Compounds - 1 ring , Piperazine (N-alkylpiperazine)<br><br>Indication(s): Symptomatic relief of anxiety and tension associated with psychoneuroses, and as an adjunct in organic disease states in which anxiety is manifested. Also, it's indicated in treatment of histamine-mediated pruritus and pruritis due to allergic conditions such as chronic urticaria.&nbsp;<br><br>Target(s): Targets anxiety without serotonin reuptake inhibition and without effect of GABA.&nbsp;<br><br>Mechanism of action(s): The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. It's an inverse agonist so rather than blocking activity at a receptor, they actively dampen its activity. (responsible for allergic symptoms such as pruritus, rhinorrhea, and watery eyes)<br><br>Role of drug w/ target: The target in Hydroxyzine is an inverse agonist, so Hydroxyzine's role is to help control anxiety and tension caused by nervous and emotional conditions. Also, it produces sleep before surgery and relieves symptoms of allergic conditions.<br><br>Dermatoses: Any skin defect or lesion on the skin (systemic) - may include psoriasis. Hydroxyzine stops itching in Dermatoses by blocking the action of histamine which is a substance that causes allergic symptoms in the whole body.<br><br>Side Effects of Drug: Irregular or slow heart rate, hives, itching, or skin rash, fast heartbeat, difficulty swallowing, chest pain, discomfort, or tightness, puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue, trouble breathing, etc.</div>]]></description>
         <enclosure url="http://www.t3db.ca/structures/T3D2823/image.png" />
         <pubDate>2022-08-24 18:30:52 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270468623</guid>
      </item>
      <item>
         <title>Madison Peters</title>
         <author>mlpeter2</author>
         <link>https://padlet.com/hoangle/ale/wish/2270473249</link>
         <description><![CDATA[<div>Assigned Drug: Valganciclovir<br><br>Structure: Image attached above<br><br>Functional Groups: Ether, Primary Alcohol, &amp; Carbamate<br><br>Heterocycle: Purine<br><br>Indication: Cytomegalovirus<br><br>Target: DNA<br><br>MOA: Valganciclovir is rapidly converted to ganciclovir in the body. Ganciclovir is phosphorylated to a substrate which competitively inhibits the binding of deoxyguanosine triphosphate to DNA polymerase resulting in inhibition of viral DNA synthesis.<br><br>Interaction With Target: Enzyme inhibitor–inhibits the binding of deoxyguanosine triphosphate to DNA polymerase resulting in inhibition of viral DNA synthesis.</div><div><br></div><div>Side effects:&nbsp;</div><ul><li>Hypertension</li><li>Headache</li><li>Insomnia</li><li>Diarrhea</li><li>Nausea</li><li>Vomiting</li><li>abdominal pain</li><li>Anemia</li><li>Thrombocytopenia</li><li>Neutropenia</li><li>Graft rejection</li><li>Tremor</li><li>Retinal detachment&nbsp;</li><li>Increased serum creatinine</li><li>Fever&nbsp;</li></ul>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774283022/e721dfbfc3d6ff47160da94fcdc454c8/Screen_Shot_2022_08_24_at_1_15_47_PM.png" />
         <pubDate>2022-08-24 18:34:42 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270473249</guid>
      </item>
      <item>
         <title>Molly Bohanan</title>
         <author>mmbohana</author>
         <link>https://padlet.com/hoangle/ale/wish/2270473636</link>
         <description><![CDATA[<div>Assigned drug: Tiotropium<br><br>Structure: image attached <br><br>Functional groups: Alcohols, Quaternary ammonium cations, Esters, and Sulfur Containing Compounds<br><br>Heterocycles: Epoxide, 2 Thiophenes<br><br>Indication: COPD (chronic obstructive pulmonary disease) and Asthma <br><br>Targets: works by blocking the muscarinic receptors for the neurotransmitter acetylcholine (Ach); Anticholinergic Agent; Anticholinergic Agent, Long-acting<br><br>Mechanism of Action: Tiotropium competitively and reversibly inhibits the action of acetylcholine (ACh) at type 3 muscarinic (M<sub>3</sub>) receptors in bronchial smooth muscle causing bronchodilation <br><br>Role: Tiotropium is a competitive muscarinic receptor antagonist. It is a anticholinergic agent that is long-acting. <br><br>Side effects: Gastrointestinal - constipation, xerostomia; Neurologic - headache; Renal - UTI disease; Respiratory - bronchitis, cough, pharyngitis, sinusitis, upper respiratory infection. These are the more common side effects. The more serious side effects include: Gastrointestinal - bowel obstruction; Immunologic - hypersensitivity reaction (immediate); Ophthalmic - angle-closure glaucoma; Renal - urinary retention; Respiratory - paradoxical bronchospasm.</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774149343/beffae7563a057ed900641899deabaf8/Screen_Shot_2022_08_24_at_1_12_14_PM.png" />
         <pubDate>2022-08-24 18:35:04 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270473636</guid>
      </item>
      <item>
         <title>Jordyn Wagner </title>
         <author>jawagne4</author>
         <link>https://padlet.com/hoangle/ale/wish/2270493255</link>
         <description><![CDATA[<div>Assigned Drug: Fenofibrate<br><br>Structure: image attached<br><br>Functional Groups: halogenated hydrocarbon ring, ketone, alkyl benzene ring, ether, ester, alkane<br><br>Heterocycles: None<br><br>Indication: Adults with primary hypercholesterolemia, mixed dyslipidemia, and severe hypertriglyceridemia&nbsp;<br><br>Targets: reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (total-c), Triglycerides (TG) and apolopoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C)<br><br>Mechanism of Action:&nbsp; activates peroxisome proliferator activated receptor alpha (PPARα), increasing lipolysis, activating lipoprotein lipase, and reducing apoprotein C-III. PPARα is a nuclear receptor and its activation alters lipid, glucose, and amino acid homeostasis. Activation of PPARα activates transcription of gene transcription and translation that generates peroxisomes filled with hydrogen peroxide, reactive oxygen species, and hydroxyl radicals that also participate in lipolysis. This mechanism of increased lipid metabolism is also associated with increased oxidative stress on the liver. In rare cases this stress can lead to cirrhosis and chronic active hepatitis.<br><br>Common Side Effects:&nbsp;</div><ul><li>stomach pain,</li><li>back pain,</li><li>headache, or</li><li>runny or stuffy nose</li><li>stomach pain</li></ul><div>Less Common Side Effects:&nbsp;</div><ul><li>gallstones and</li><li>liver problems</li></ul><div>Serious but Unlikely Side Effects</div><ul><li>severe stomach/abdominal pain,</li><li>persistent nausea/vomiting,</li><li>yellowing eyes or skin (jaundice),</li><li>dark urine,</li><li>unusual muscle pain,</li><li>tenderness, or</li><li>weakness especially if accompanied by fever or flu-like symptoms</li></ul><div><br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774282692/f44ae22e668bbbd997abb1aa4b3ee3de/imgsrv.png" />
         <pubDate>2022-08-24 18:53:25 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270493255</guid>
      </item>
      <item>
         <title>Olivia Price</title>
         <author>ocprice1</author>
         <link>https://padlet.com/hoangle/ale/wish/2270500384</link>
         <description><![CDATA[<div>Assigned Drug: amlodipine<br><br>Structure: image attached<br><br>Functional group: halogenated hydrocarbon,&nbsp; amine, ester, ether&nbsp;<br><br>Heterocycles: pyridine<br><br>Indication: angina, hypertension<br><br>Target:&nbsp;calcium ion inhibitor <br><br>MOA: Inhibits calcium ion from entering the slow channels or select voltage-sensitive areas of vascular smooth muscle and myocardium during depolarization, producing a relaxation of coronary vascular smooth muscle and coronary vasodilation<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774110066/2fbd536a68675488ee350dbd12b3ac87/download.png" />
         <pubDate>2022-08-24 19:01:24 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270500384</guid>
      </item>
      <item>
         <title>Maria Sallee</title>
         <author>mrsallee</author>
         <link>https://padlet.com/hoangle/ale/wish/2270501943</link>
         <description><![CDATA[<div>Assigned Drug: Diazepam&nbsp;<br><br>Structure: Image Attached&nbsp;<br><br>Functional Groups: Halogen (-Cl), Benzene, Amide, Methyl&nbsp;<br>Heterocycles: Benzodiazepine&nbsp;<br><br>Indication: Anxiety, seizures, substance withdrawal, muscle spasms<br><br>Target: GABA(A) receptor&nbsp;<br><br>Mechanism of Action: GABA is an inhibitory transmitter. By binding to the GABA(A) receptors, diazepam increases the inhibitory effects of GABA, leading to increased permeability of chloride ions and hyperpolarization. This leads to sedation, muscle relaxation, and anti-seizure activity.&nbsp;<br><br>Role of target: Positive allosteric modulator<br><br>Minor side effects: Drowsiness, muscle weakness&nbsp;<br>Serious side effects: Shortness of breath/troubled breathing, confusion, hallucinations, memory loss, passing out, change in eyesight, slurred speech, loss of appetite that does not go away, increased risk of suicidal thoughts.<br><br>Sources: Lexicomp, MicroMedex, and DrugBank</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286216/8449d8cdcc4374962ff1f722b81e72d9/Screen_Shot_2022_08_24_at_1_08_28_PM.png" />
         <pubDate>2022-08-24 19:03:13 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270501943</guid>
      </item>
      <item>
         <title>Mohamed Marzouk</title>
         <author>momarzou</author>
         <link>https://padlet.com/hoangle/ale/wish/2270504666</link>
         <description><![CDATA[<div>- Assigned Drug: Topiramate<br><br>- Structure: image attached <br><br>- Function groups: Ethers &amp; Oxides,Sulfur Containing Compounds<br><br>- Heterocycles: None<br><br>- Indication: Migraine, prevention<strong>:</strong> Prophylaxis of migraine headache in patients ≥12 years of age and <strong>Seizures:</strong> Monotherapy or adjunctive therapy in patients ≥2 years of age (immediate release and Qudexy XR) or ≥6 years of age (Trokendi XR) with focal (partial) onset or primary generalized tonic-clonic seizures; adjunctive therapy in patients ≥2 years of age (immediate release and Qudexy XR) or ≥6 years of age (Trokendi XR only) with seizures associated with Lennox-Gastaut syndrome<br><br>- Targets: voltage-dependent sodium channels, GABA receptors, and glutamate receptors<br><br>- Mechanism of Action: Antiseizure activity may be due to a combination of potential mechanisms: Blocks neuronal voltage-dependent sodium channels, enhances GABA(A) activity, antagonizes AMPA/kainate glutamate receptors, and weakly inhibits carbonic anhydrase.<br><br>- Side Effects:&nbsp;upset stomach, throwing up, constipation, weight loss, change in taste, diarrhea, stomach pain, anxiety, feeling sleepy/tired/weak, common cold symptoms, joint pain, headache, and flushing<br><br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774280315/69673197756bfd97f4baba36c3566edb/360_F_184277923_W0JSq66FOBXxsmWdH6zjbfkk8hd2Cs0Z.jpg" />
         <pubDate>2022-08-24 19:06:16 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270504666</guid>
      </item>
      <item>
         <title>Jason Jennings</title>
         <author>jtjenni2</author>
         <link>https://padlet.com/hoangle/ale/wish/2270505565</link>
         <description><![CDATA[<div>Assigned drug: levetiracetam<br><br>Structure image attached<br><br>Functional groups: amide<br><br>Heterocycles: phenol, piperidin, indazole<br><br>Indication: for the treatment of partial-onset seizures (antiepileptic)<br><br>Target: possibly Calcium channel (inhibitor), GABA (inhibitor)<br><br>Mode of action:&nbsp;<br>(unknown)<br>It is suggested that the mechanism may involve one or more of the following central pharmacologic effects: inhibition of voltage-dependent N-type calcium channels; facilitation of GABA-ergic inhibitory transmission through displacement of negative modulators; reduction of delayed rectifier potassium current; and/or binding to synaptic proteins which modulate neurotransmitter release.<br><br>Side Effects:&nbsp;<br>(significant):<br>1. CNS Depression<br>2. Hypersensitivity Reactions (delayed)<br>3. Psychiatric and Behavioral Abnormalities<br><br>(common)<br>1. increased blood pressure<br>2. vomiting<br>3. infection<br>4. Asthenia (neuromuscular/skeletal)<br>5. Nasopharyngitis<br>6. behavioral problems, drowsiness, fatigue<br><br><br>sources:&nbsp;<br>1. DailyMed. accessed 9-29-22. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c508a392-0603-477d-8a45-3ec550371111<br>2. Lexicomp. accessed 9-29-22. https://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/7162?cesid=0aE98vSuI5Z&amp;searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3DlevETIRAcetam%26t%3Dname%26acs%3Dtrue%26acq%3Dlevetir#<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1416699277/cf2aa892c06e6ee41ee2e8702fd9646a/image.webp" />
         <pubDate>2022-08-24 19:07:17 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270505565</guid>
      </item>
      <item>
         <title>Baylee Smith</title>
         <author>bmsmith13</author>
         <link>https://padlet.com/hoangle/ale/wish/2270509613</link>
         <description><![CDATA[<div>Assigned Drug: Enalapril&nbsp;<br>Structure: above&nbsp;<br>Functional Groups: carboxylic acid, phenyl, ester, amide, secondary amine<br>Heterocycle: Pyrrolidine&nbsp;<br>Indication(s): high blood pressure, diabetic kidney disease, and heart failure<br>Target: angiotensin-converting enzyme&nbsp;<br>Mechanism of Action: Competitive inhibitor of angiotensin-converting enzyme (ACE), prevents conversion of angiotensin I to angiotensin II, increases plasma renin activity and reduces aldosterone secretion<br>Role: ACE inhibitor&nbsp;<br>Side effects: Blurred vision, confusion, dizziness, sweating, tiredness, nausea, diarrhea, dry mouth</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286175/1a61472c6fbac38054777aac0b677fb9/enalapril.png" />
         <pubDate>2022-08-24 19:11:21 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270509613</guid>
      </item>
      <item>
         <title>Andrew Nguyen</title>
         <author>atnguye4</author>
         <link>https://padlet.com/hoangle/ale/wish/2270519354</link>
         <description><![CDATA[<div>Assigned Drug: Oseltamivir<br><br>Structure: (Image Attached)<br><br>Functional Groups: Alkene, Ether, Ester, Amide, Amine<br><br>Heterocycles: pyrazole, indole, imidazole, thiazole, pyridine, quinaxoline<br><br>Indication: Seasonal Influenza<br><br>Target: It inhibits the influenza virus neuraminidase.<br><br>MoA: It is a prodrug that is hydrolyzed to its active form. It then acts as an neuraminidase inhibitor. It prevents the influenza virus from cleaving its viral progeny from its cellular envelope.<br><br>Role: Neuraminidase Enzyme Inhibitor<br><br>Side Effects: Diarrhea, Nausea, Vomiting, Headache, Confusion, Behavioral Changes, Trouble Speaking, Tremors, Seizures, Sensing things that are not there, and Stevens-Johnson Syndrome<br><br>Sources:&nbsp;<br>https://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/7405?cesid=8hqeiIJa3L4&amp;searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Doseltamivir%26t%3Dname%26acs%3Dfalse%26acq%3Doseltamivir<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774287101/48cd51e498434f138ce5294999f62872/Oseltamivir_svg.png" />
         <pubDate>2022-08-24 19:22:36 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270519354</guid>
      </item>
      <item>
         <title>Dakota Jones</title>
         <author></author>
         <link>https://padlet.com/hoangle/ale/wish/2270531566</link>
         <description><![CDATA[<div>Assigned Drug: Spironolactone<br>Structure: attached image<br>Functional Groups: Ketone, Ester functionality that is the lactone heterocycle, Carbon double bonds, Ketone attatched to cyclic structure, Methyl<br>Heterocycles: Lactone</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1780630162/1ff54a70aafb739f663ef1c16250c1db/Screen_Shot_2022_08_24_at_1_55_15_PM.png" />
         <pubDate>2022-08-24 19:36:44 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270531566</guid>
      </item>
      <item>
         <title>Kiki Meredith</title>
         <author>kamered1</author>
         <link>https://padlet.com/hoangle/ale/wish/2270549593</link>
         <description><![CDATA[<div>Assigned Drug: Oxycodone<br>Structure: Image<br>Functional Groups: Aromatic Ether, alcohol, Keto, Cyclohexane<br>Heterocycles: Tetrahydrofuran, Piperidine<br>Indication: Pain Management&nbsp;<br>Target: opiate receptors<br>Mechanism of Action: It binds to opiate receptors in the CNS, which inhibits the ascending pain pathways, this alters the perception and response to pain. It depresses the CNs.&nbsp;<br>Side effects:  Allergic reaction signs, very dizzy or passing out, feeling confused, severe constipation or stomach pain, trouble breathing, slow breathing, shallow breathing, noisy breathing, sleep apnea, trouble passing urine, fast, slow, or abnormal heartbeat, seizures, shakiness, change in eyesight, chest pain or pressure, hallucinations, mood changes, memory problems or loss, trouble walking, trouble speaking, swelling in the arms or legs, fever, sleepy, tired, weak, headache, trouble sleeping, itching, dry mouth, diarrhea, upset stomach, throwing up, or decreased appetite.  (listed from Lexicomp)<br>&nbsp;<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774281806/a13130df05bb9b51479d28efcfdeecd7/oxycodone.png" />
         <pubDate>2022-08-24 19:58:00 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270549593</guid>
      </item>
      <item>
         <title>Kaitlin Jacobwith</title>
         <author>ksjacobw</author>
         <link>https://padlet.com/hoangle/ale/wish/2270564227</link>
         <description><![CDATA[<div>Assigned Drug: Pregabalin&nbsp;<br><br>Structure: image attached above&nbsp;<br><br>Functional groups: Carboxylic acid, Primary amine<br><br>Heterocycles: None<br><br>Indication:&nbsp;<br>-Fibromyalgia&nbsp;<br>-Neuropathy associated with diabetes<br>-Postherpetic Neuralgia&nbsp;<br>-Seizures<br><br>Target:&nbsp;<br>-Alpha-2-delta subunit of voltage-gated calcium channels<br><br>MOA:&nbsp;<br>Binds to alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system and regulates calcium influx. This results in the inhibition excitatory neurotransmitter release.<br><br>Role of drug: Antagonist of voltage gated Ca2+ channels</div><div><br></div><div>Indication:&nbsp;</div><div>-Fibromyalgia&nbsp;</div><div>-Neuralgia&nbsp;</div><div>-Seizures</div><div><br></div><div>Side Effects:</div><div>-CNS depression&nbsp;</div><div>-Respiratory depression</div><div>-Delayed hypersensitivity reactions&nbsp;</div><div>-Peripheral edema</div><div>-Suicidal ideation&nbsp;</div><div>-Visual disturbances&nbsp;</div><div>-Weight gain</div><div><br></div><div><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286387/e8be940e631647522eff12a4520915f1/pregabalin.png" />
         <pubDate>2022-08-24 20:19:23 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270564227</guid>
      </item>
      <item>
         <title>Tristan (Tông) Tran</title>
         <author>tdtran4</author>
         <link>https://padlet.com/hoangle/ale/wish/2270609227</link>
         <description><![CDATA[<div>-Assigned Drug: Loratadine&nbsp;<br><br>-Functional Groups: tert-Amine, ester<br><br>-Heterocysts: Pyridine<br><br>-Indication: children's Claritin, temporarily relieve hay fever and allergies<br><br>-Targets:&nbsp;H1-receptors, specifically in the periphery<br><br>-MOA: Long-acting tricyclic antihistamine with selective peripheral histamine H1-receptor antagonistic properties</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1404390455/b7253a76e0a8c013bee14caeecd12890/1200px_Loratadine_svg.png" />
         <pubDate>2022-08-24 21:27:31 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270609227</guid>
      </item>
      <item>
         <title>Connor Callahan</title>
         <author>cmcallah</author>
         <link>https://padlet.com/hoangle/ale/wish/2270669933</link>
         <description><![CDATA[<div>Assigned Drug:&nbsp; Docusate&nbsp;<br><br>Structure: Image attached&nbsp;<br><br>Functional Group: Esters and Sulfones&nbsp;<br><br>Heterocycles: None&nbsp;<br><br>Indication=the treatment of constipation associated with dry, hard stools or opioid induced constipation<br><br>Targets: Feces and stools, mostly in the small intestine<br><br>Mechanism of action: Anionic Surfactant, It lowers the surface tension at the oil-water interface of the feces, allowing water and lipids to penetrate the stool. This helps to hydrate and soften the fecal material, facilitating elimination of feces.&nbsp;<br><br>Role: Unknown (Stool Softener)<br><br>Common Side Effects: Abdominal Cramps, Nausea, Diarrhea,  bitter taste <br><br>Serious Side effects: Rectal Irritation, Signs of allergic reaction (rashes, itching, blistered, etc.)  &nbsp;&nbsp;<br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774288136/a2c5d415141f16a7045dc90708723da8/Docusate.png" />
         <pubDate>2022-08-24 23:19:07 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270669933</guid>
      </item>
      <item>
         <title>Lisinopril</title>
         <author>alander71</author>
         <link>https://padlet.com/hoangle/ale/wish/2270734616</link>
         <description><![CDATA[<div>Assigned Drug: Lisinopril&nbsp;<br><br>Structure: Image Attached<br><br>Functional Groups: Secondary Amine, Carboxylic Acid, Benzene, Tertiary Amine, Primary Amine<br><br>Heterocycles: Pyrrolidine<br><br>Indication: Acute Myocardial Infarction, Hypertension, Adjunct Therapy for Heart Failure<br><br>Targets: Angiotensin-Converting Enzyme &amp; Renin<br><br>MOA: An angiotensin converting enzyme inhibitor (ACEI), preventing the conversion of angiotensin I to angiotensin II. This action prevents myocyte hypertrophy and vascular smooth muscle cell proliferation seen in untreated patients.<br><br>Interaction with Target: Enzyme Inhibitor<br><br>Indication of Drug: The treatment of acute myocardial infarction, hypertension in patients &gt; 6 years, and as an adjunct therapy for heart failure<br><br>Side Effects: Dry Cough, Dizziness, Headaches, Vomiting, Diarrhea, Itching, Blurred Vision</div>]]></description>
         <enclosure url="https://www.abmole.com/upload/structure/Lisinopril.gif" />
         <pubDate>2022-08-25 00:35:48 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270734616</guid>
      </item>
      <item>
         <title>Caroline Tennison </title>
         <author>cgtennis</author>
         <link>https://padlet.com/hoangle/ale/wish/2270750778</link>
         <description><![CDATA[<div>Assigned Drug: Trazodone <br><br>Structure: Attached<br><br>Functional Groups: urea, halogenated benzene ring<br>&nbsp;<br>Heterocycles: piperazine, triazole<br><br>Indication: Treatment of Unipolar Major Depressive Disorder <br><br>Targets: 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2C, Sodium-dependent serotonin transporter, 5-hydroxytryptamine receptor 1A, Histamine H1 receptor<br><br>MOA: Inhibits reuptake of serotonin, causes adrenoreceptor subsensitivity, acts as a 5HT<sub>2a</sub> receptor antagonist and induces significant changes in 5-HT presynaptic receptor adrenoreceptors. Trazodone also significantly blocks histamine (H<sub>1</sub>) and alpha1-adrenergic receptors.<br><br>Role of Drug in Interaction with the Target: Serotonin Reuptake Inhibitor/Antagonist&nbsp;<br><br>Side Effects: Nausea and vomiting, xerostomia, dizziness, drowsiness, fatigue, headache, nervousness, blurred vision<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286059/046fe85262583e13a75179635ba46e18/FE619E16_C3B0_479D_ABE7_7591DD47B4B8.png" />
         <pubDate>2022-08-25 00:49:23 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270750778</guid>
      </item>
      <item>
         <title>Haley Harlan</title>
         <author></author>
         <link>https://padlet.com/hoangle/ale/wish/2270751328</link>
         <description><![CDATA[<div>1. Paroxetine<br>2. Ether, fluorophenyl<br>3. Piperidine, benzodioxole<br>4. Indication- generalized anxiety disorder, major depressive disorder, obsessive compulsive disorder, panic disorder, PTSD, premenstrual dysphoric disorder, social anxiety disorder, vasomotor symptoms of menopause<br>5. Targets- Synaptic Serotonin Reuptake Transporter, inhibits CYP2D6<br>6. MOA- SSRI, inhibition of serotonin reuptake from the brain causes a synapse stimulated serotonin activity in the brain<br>7. Enzyme inhibitor- Selective serotonin reuptake inhibitor<br>8. Indications- body dysmorphic oder, generalized anxiety order, major depressive disorder, obsessive compulsive disorder, panic disorder, post traumatic stress disorder, premature 🤬, premenstrual dysphoric disorder, social anxiety disorder, vasomotor symptoms of menopause<br>8. Side effects: activation of mania or hypomania, bleeding risk, fragility fractures, hypotranemia, ocular effects, serotonin syndrome, sexual dysfunction, suicidal thinking and behavior, withdrawal syndrome</div><div><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774287301/e7994a516a62581c7ccebec9a71ed8b1/79F634D3_812D_4F3C_8AB1_5401AA232553.png" />
         <pubDate>2022-08-25 00:49:54 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270751328</guid>
      </item>
      <item>
         <title>Faith Houston</title>
         <author>fchousto</author>
         <link>https://padlet.com/hoangle/ale/wish/2270764081</link>
         <description><![CDATA[<div>Drug: finasteride<br><br>Functional Groups: 2 amides and a cyclic cis double bond.<br><br>Heterocycles: none<br><br>Indication: <br>Androgenetic alopecia (male pattern hair loss), Benign prostatic hyperplasia --&gt; reduce the risk of acute urinary retention and reduce the risk of the need for BPH-related surgery; used in combination with an alpha-1 adrenergic antagonist to reduce the risk of symptomatic progression.<br><br>Target: steroid-5-alpha-reductase<br><br>Mechanism of Action: <br>Finasteride competitively inhibits steroid-5-alpha-reductase, resulting in inhibition of the conversion of testosterone to dihydrotestosterone and markedly suppresses serum dihydrotestosterone levels<br><br>Side Effects:<br>Finasteride may cause sexual dysfunction, including <strong>impotence</strong>, <strong>decreased libido</strong>, <strong>ejaculatory disorder</strong>, and <strong>sexual disorder</strong>, which may persist after discontinuation. Of note, it has been hypothesized that persistent sexual dysfunction may contribute to psychological adverse reactions (eg, <strong>anxiety </strong>and <strong>depression</strong>) and <strong>suicidal ideation</strong> and <strong>suicidal tendencies</strong> in younger patients treated for alopecia.<br>The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</div><div>&gt;10%: Genitourinary: Impotence (5% to 19%)</div><div>1% to 10%:</div><div>Cardiovascular: Hypotension (1%), orthostatic hypotension (9%), peripheral edema (1%)</div><div>Endocrine &amp; metabolic: Decreased libido (2% to 10%), gynecomastia (1% to 2%)</div><div>Genitourinary: Breast tenderness (≤1%), decreased 🤬 volume (2% to 4%), ejaculatory disorder (≤7%), prostate cancer - high grade (2%), sexual disorder (3%)<br><br>Source: Lexicomp https://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/6913?cesid=0aUYqwO57tF&amp;searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dfinasteride%26t%3Dname%26acs%3Dtrue%26acq%3Dfin# <br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286358/75283c164b2a04933f10bda506b7f2e5/finasteride.png" />
         <pubDate>2022-08-25 01:01:58 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270764081</guid>
      </item>
      <item>
         <title>Chloe Bergman </title>
         <author>cmbergma</author>
         <link>https://padlet.com/hoangle/ale/wish/2270837543</link>
         <description><![CDATA[<div>Assigned Drug: Simvastatin&nbsp;<br><br>Structure: image attached&nbsp;<br><br>Functional Groups: ester group, alcohol, methyl groups, propane, alkenes<br><br>Heterocycles: delta-lactone&nbsp;<br><br>Indication: hypercholesterolemia&nbsp;<br><br>Target: HMG-CoA reductase&nbsp;<br><br>Role: Competitive Antagonist&nbsp;<br><br>Mechanism of Action: competitively inhibits 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (which catalyzes the rate limiting step in cholesterol biosynthesis). This decreases level of high sensitivity C-reactive protein (hsCRP) and improves endothelial function, reduces inflammation at the site of coronary plaque, inhibits platelet aggregation and has anticoagulant effects.<br><br>Side Effects:&nbsp;<br>-hepatotoxicity<br>-muscle effects: myalgia, myopathy, rhabdomyolysis, immune-mediated necrotizing myopathy&nbsp;<br>-cardiovascular: atrial fibrillation, edema<br>-dermatologic: eczema&nbsp;<br>-gastrointestinal: abdominal pain, constipation, gastritis, nausea<br>-nervous system: headache, vertigo </div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286444/c8455645d222e28ed67ab80b3dfa9d55/Chemical_structure_of_simvastatin.png" />
         <pubDate>2022-08-25 02:07:35 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270837543</guid>
      </item>
      <item>
         <title>Maddie Trapani</title>
         <author>mltrapan</author>
         <link>https://padlet.com/hoangle/ale/wish/2270846117</link>
         <description><![CDATA[<div>Assigned drug: Alprazolam&nbsp;<br><br>Structure: image above<br><br>Functional groups: phenyl, methyl, chloro substituent, secondary amines<br><br>Heterocycles: triazole<br><br>Indication: generalized anxiety disorder, panic disorder<br><br>Target: GABA(A) receptor<br>&nbsp;<br>Role: positive allosteric modulator&nbsp;<br><br>MOA: Alprazolam is a benzodiazepine that exerts its effect for the acute treatment of generalized anxiety disorder and panic disorder through binding to the benzodiazepine site of gamma-aminobutyric acid-A (GABAA) receptors in the brain and enhancing GABA-mediated synaptic inhibition.&nbsp;<br><br>Side effects: impaired or abnormal coordination, hypotension, dysarthria, increased or decreased libido, somnolence, memory impairment, ataxia, constipation, and nausea<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286733/f79cf267534d488db20634ce5949b026/1527.jpg" />
         <pubDate>2022-08-25 02:14:47 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270846117</guid>
      </item>
      <item>
         <title>Matthew Bobo</title>
         <author>mwbobo</author>
         <link>https://padlet.com/hoangle/ale/wish/2270883529</link>
         <description><![CDATA[<div>Assigned Drug: Losartan<br><br>Structure: Image Attached&nbsp;<br><br>Functional Groups: primary alcohol, benzene ring, halogenated compound<br><br>Heterocycles: imidazole, tetrazole<br><br>Indication: Hypertension<br><br>Target: Angiotensin II Receptor<br><br>MOA: As a selective and competitive, nonpeptide angiotensin II receptor antagonist, losartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II<br><br>Side Effects: chest pain, dizzy, diarrhea, low blood sugar, kidney problems, swelling in arms or legs</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286236/e3cdc835e159b9433250a8a9e05155c7/image.png" />
         <pubDate>2022-08-25 02:47:46 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270883529</guid>
      </item>
      <item>
         <title>Lana Taylor</title>
         <author>lltaylo4</author>
         <link>https://padlet.com/hoangle/ale/wish/2270961261</link>
         <description><![CDATA[<div>-Assigned Drug: Amphetamine&nbsp;<br><br>-Functional Groups: one phenyl group and one primary amine&nbsp;<br><br>-There are no heterocycles in amphetamine&nbsp;<br><br>- Indications: Attention-deficit/hyperactivity disorder and Narcolepsy (immediate-release tablets only)<br><br>- Targets: pre-synaptic neurotransmitters that are responsible for releasing catecholamines&nbsp;<br><br>-Mechanism of Action: Amphetamines stimulate the release of catecholamines (mainly norepinephrine and dopamine) from pre-synaptic neurons. Amphetamines are able to block the re-uptake of catecholamines by competitive inhibition.&nbsp;<br><br>- Interaction with the target: Amphetamines are considered nonselective indirect agonist for adrenergic receptors that increase the overall concentration of extracellular norepinephrine, dopamine, and serotonin.&nbsp;<br><br>- Side effects include weight loss, decreased appetite, nausea, abdominal pain, headache, dizziness, insomnia, mood swings, anxiety, agitation, myocardial infarction, sudden cardiac death, cerebrovascular events, and psychotic disorder.&nbsp;<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1772567586/2eebf63b65f4d32b1306a133597a159c/Amphetamine.png" />
         <pubDate>2022-08-25 04:13:19 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2270961261</guid>
      </item>
      <item>
         <title>Tuong Tran</title>
         <author>tmtran2</author>
         <link>https://padlet.com/hoangle/ale/wish/2271011793</link>
         <description><![CDATA[<div>Assigned Drug: Naproxen<br><br>Structure: (See Attached Image)<br><br>Functional Groups: Naphthalene, Aromatic Ether, Carboxylic Acid<br><br>Heterocycles: None<br><br>Indications: Inflammation (primarily for various forms of arthritis), Pain (including dysmenorrhea/menstrual pain)<br><br>Drug Targets: Cyclooxygenase-1 and Cyclooxygenase-2 (COX-1 and COX-2)&nbsp;<br><br>Mechanism of Action: Naproxen non-selectively inhibits COX-1 and COX-2 proteins which catalyze the creation of prostaglandins from arachidonic acid; this leads to a reduction in inflammatory response.<br><br>Drug Role: Enzyme inhibitor&nbsp;<br><br>Black Box Warning: Increased risk of serious cardiovascular thrombotic event; Increased risk of GI bleeding<br><br>Common Side Effects: Indigestion, Headache, Nausea, Dizziness, Drowsiness, Edema, Itchy skin, Rash, Abdominal pain, Heart burn, Constipation, Difficulty breathing, Ringing in ears<br><br>Serious Side Effects: Cardiovascular events (e.g. Stroke and Myocardial infarction), Hepatotoxicity, Kidney injury, Bleeding events (GI ulceration or perforation)&nbsp;</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774287132/1be6fefaa12390584166e52c25efd6ff/Naproxen_structure.PNG" />
         <pubDate>2022-08-25 05:12:45 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271011793</guid>
      </item>
      <item>
         <title>Faith Boettcher</title>
         <author>flboettc</author>
         <link>https://padlet.com/hoangle/ale/wish/2271415857</link>
         <description><![CDATA[<div>- Assigned Drug: Latanoprost&nbsp;<br>- Structure: Pictured<br>- Functional Groups: Secondary Alcohol, Ester, Benzyl?<br>- Heterocycles: none!<br>-Indication: Ocular Hypertension; Open-Angle Glaucoma<br>-Target: F2-Alpha<br>-MOA: A prostaglandin F2-alpha analogue that reduces the intraocular pressure by increasing outflow of aqueous humor. The main mechanism is increased uveoscleral outflow.&nbsp;<br>-Side Effects: Blurred vision, burning sensation in eye, conjunctival hyperemia, foreign body sensation, hyperemia of eye, iris color change, itching of eye, pain in eye, superficial punctate keratitis, influenza, nasopharyngitis, upper respiratory infection, bacterial keratitis, reactivation, cystoid macular edema, herpes simplex keratitis, iridocyclitis, macular retinal edema</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774285014/6c65fb4dfe249a892b03b65ae88eab88/Latanoprost_Structure.png" />
         <pubDate>2022-08-25 13:24:41 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271415857</guid>
      </item>
      <item>
         <title>Luke Carr</title>
         <author>clcarr1</author>
         <link>https://padlet.com/hoangle/ale/wish/2271446073</link>
         <description><![CDATA[<div>Assigned Drug: Venlafaxine&nbsp;<br>Functional Groups: tertiary alcohol, ether, tertiary amide, phenyl<br>Heterocycles: none<br>Indications for use: Generalized Anxiety Disorder, Major Depressive Disorder, Panic disorder, Social Phobia</div><div>Target: Serotonin and Norepinephrine Reuptake</div><div>Mechanism of Action: The active metabolite of venlafaxine, O-desmethylvenlafaxine, inhibits serotonin and norepinephrine reuptake<br>Role: Inhibitor&nbsp;</div><div>Side Effects (Common): Hypertension, Sweating, Weight loss, Constipation, Nausea, Dizziness, Headache, Insomnia Somnolence, Tremor, Abnormal 🤬, erectile dysfunction, reduced libido</div><div>Side effects (serious): Hyponatremia, Hemorrhage, Hepatitis, Rhabdomyolysis, Seizure, Depression, Exacerbation, Mania, Suicidal thoughts, Interstitial Lung disease, Pulmonary eosinophilia, Neuroleptic malignant syndrome, Serotonin syndrome&nbsp;</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286725/96497c86a9aca497c5c94282e53b2654/download.png" />
         <pubDate>2022-08-25 13:46:32 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271446073</guid>
      </item>
      <item>
         <title>Parker Sumrall</title>
         <author>dpsumral</author>
         <link>https://padlet.com/hoangle/ale/wish/2271504223</link>
         <description><![CDATA[<div>Assigned Drug: Atenolol<br><br>Structure: Image Attached<br><br>Fuctional groups: One amide, One benzene ring, One ester, One secondary alcohol, One secondary amine<br><br>Heterocycles: None<br><br>Indications: Angina, Hypertension, Myocardial Infarction<br><br>Target: beta-1 adrenergic receptor</div><div><br>MOA: atenolol competitively blocks beta-1 receptors, blocking beta-1 stimulation. Has little to no effect on beta-2 receptors.&nbsp;<br><br>Common Side Effects: Bradyarrhythmia, cold extremities, hypotension, dizziness, depression, and fatigue<br><br>Serious Effects: Heart failure, myocardial infarction, ventricular arrhythmia, thyrotoxicosis, anaphylaxis, systemic lupus erythematosus, pulmonary embolism, withdrawal symptoms. </div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286183/bd8a71bf7cb916adfa549c9f096fadb5/Atenolol.png" />
         <pubDate>2022-08-25 14:30:27 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271504223</guid>
      </item>
      <item>
         <title>Elizabeth Roberts</title>
         <author>erobert22</author>
         <link>https://padlet.com/hoangle/ale/wish/2271514229</link>
         <description><![CDATA[<div>Assigned Drug: Gabapentin<br><br>Structure: Image Attached<br><br>Functional Groups: Carboxylic acid, Primary Amine<br><br>Heterocycles: None<br>&nbsp;<br>Indications: partial seizures, nerve pain, restless leg syndrome<br><br>Targets: inhibits voltage-gated calcium channels<br><br>Mechanism of Action: crosses membranes via L amino acid transporters, reduces the release of mono-amine transmitters, inhibits GABA enzymes<br><br>Common Side Effects: Peripheral edema, nausea, viral disease, ataxia, nystagmus, fatigue, and fever<br><br>Serious Side Effects: Stevens-Johnson syndrome, hypoglycemia, anaphylaxis, drug reaction with eosinophilia and systemic symptoms, dizziness, somnolence, disorder of form of thought, disturbance in thinking, hostile behavior, hyperactive behavior, mood swings, suicidal thoughts, respiratory depression, angioedema</div><div><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774285884/8366d29448a4c0101f06d65c773e02d3/image.png" />
         <pubDate>2022-08-25 14:38:52 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271514229</guid>
      </item>
      <item>
         <title>Aven Cates</title>
         <author></author>
         <link>https://padlet.com/hoangle/ale/wish/2271515679</link>
         <description><![CDATA[<div>Functional Group: Ether, Secondary Alcohal, Benzene Ring, Secondary amine.&nbsp;<br>Heterocycles: Pyrrolidine<br><br>The indications for carvedilol is hypertension and heart failure with reduced ejection fraction. The mechanism of action is a   nonselective beta-adrenoreceptor and alpha-adrenergic blocking activity. Its target is Beta receptors. </div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1781519559/2852a1bec51dec4d28c11cbe6faa081e/Chemical_structure_of_carvedilol.png" />
         <pubDate>2022-08-25 14:39:53 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271515679</guid>
      </item>
      <item>
         <title>Brittany Deming</title>
         <author>bddeming</author>
         <link>https://padlet.com/hoangle/ale/wish/2271521375</link>
         <description><![CDATA[<div>Assigned drug: Lamotrigine<br><br>Structure Image: Image Attached&nbsp;<br><br>Functional Groups: amino groups, primary amines,&nbsp;<br>halogenated benzene ring<br><br>Heterocycle: Triazine&nbsp;<br><br>Indication: bipolar disorder, focal onset seizures, and generalized seizures&nbsp;</div><div><br></div><div>Target: voltage sensitive sodium channels</div><div><br></div><div>MOA: triazine inhibits the release of glutamate and inhibits voltage sensitive sodium-channels which stabilizes the neuronal membrane. Lamotrigine has weak inhibitory effect of the 5-HT3 receptor, in vitro inhibits dihydrofolate reductase.<br><br>Common Side Effects: rash, abdominal pain, diarrhea, nausea, heart burn, back pain, dizziness, insomnia, somnolence, tremor, blurred vision, dysmenorrhea, rhinitis, pain in throat, fever <br><br>Serious Side Effects: Skin rashes (Steven-Johnson Syndrome), Aseptic meningitis, blood dycrasias, hypersensitivity reactions, hemophagocytic lymphohistiocytosis, suicidcal ideation/tendencies, liver failure<br><br></div>]]></description>
         <enclosure url="http://www.biopsychiatry.com/lamotrigine/lamotrigine.jpg" />
         <pubDate>2022-08-25 14:44:19 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271521375</guid>
      </item>
      <item>
         <title>Jennifer Tran </title>
         <author>jktran2</author>
         <link>https://padlet.com/hoangle/ale/wish/2271547686</link>
         <description><![CDATA[<div>Assigned Drug: Quetiapine<br><br>Structure : Image attached above&nbsp;<br><br>Functional Groups: Alcohol, Phenol, Amine<br><br>Heterocycles: Piperazine<br><br>Indication: bipolar disorder (acute treatment of mania) , major depressive disorder, and treatment of schizophrenia&nbsp;<br><br></div><div>Target: 5- Hydroxytryptamine receptors, Dopamine receptors, Histamine receptors, Monomine transport subfamily (GPCRs)</div><div><br>Mechanism of action:&nbsp; Although the mechanism of action of quetiapine is not fully understood, several proposed mechanisms could occur. in schizophrenia, its action could occur from the antagonism of dopamine type 2 and serotonin 2A receptors. in bipolar depression, its action must be attributed to the binding of the drugs or its metabolite to the norepinephrine receptor.&nbsp;</div><div><br>Role : Antagonist&nbsp;<br><br>Common side effects: feeling fatigue, headache, constipation, dry mouth, gain of appetite, weight gain, upset stomach, stomach pain, back pain, stuffy nose, feeling nervous and excitable<br><br>Serious side effects: depression , high blood sugar, infection like fevers, chills, or sore throat, low thyroid levels, neuroleptic malignant syndrome, seizures , trouble passing urine&nbsp;</div><div><br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1404408895/696257f9c2093a5fc93b9b85763c041f/91EDE7D2_60B6_45E9_84BD_3CCE8C920E0D.png" />
         <pubDate>2022-08-25 15:06:23 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271547686</guid>
      </item>
      <item>
         <title>Hannah Piatt</title>
         <author>crpiatt</author>
         <link>https://padlet.com/hoangle/ale/wish/2271567879</link>
         <description><![CDATA[<div><strong>Assigned Drug</strong>:<br>Omeprazole<br><br><strong>Structure</strong>: (image attached)<br><br><strong>Functional Groups</strong>: Amines &amp; Amine Salts,Ethers &amp; Oxides,Heterocycles,Sulfur Containing Compounds<br><br><strong>Heterocycles</strong>: Indole, Pyridine<br><br><strong>Indication</strong>: The treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease<br><br><strong>Target Receptor</strong>: CYP2C19<br>Proton pump inhibitors (PPIs) effectively block gastric acid secretion by irreversibly binding to and inhibiting the hydrogen-potassium ATPase pump that resides on the luminal surface of the parietal cell membrane<br><br><strong>Mechanism of Action</strong>: It suppresses stomach acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup>-ATPase system found at the secretory surface of gastric parietal cells. Because this enzyme system is regarded as the acid (proton, or H<sup>+</sup>) pump within the gastric mucosa, omeprazole inhibits the final step of acid production. <br><br><strong>How it interacts with its target receptor:</strong> Omeprazole directly interacts with the proton pump inhibitor. The specific inhibitor is H+,K(+)-ATPase in parietal cells<br><br><strong>Adverse Effects:</strong>&nbsp;<br>Dermatologic: Rash<br>Gastrointestianl: Abdominal pain, Constipation, Diarrhea, Flatulence, Nausea, Vomitting<br>Neurologic: Dizziness and Headache<br>Respiratory: Upper respiratory infection<br>Other: Fever<br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1305482561/fab1dab2bf48af149ace81272b824da5/Omeprazole_300.png" />
         <pubDate>2022-08-25 15:22:49 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271567879</guid>
      </item>
      <item>
         <title>Sam Hudson</title>
         <author>shudson62</author>
         <link>https://padlet.com/hoangle/ale/wish/2271576398</link>
         <description><![CDATA[<div>Assigned Drug: Sildenafil<br><br>Structure: image attached&nbsp;<br><br>Functional Groups: Phenylether, Sulfonamide, Tertiary Amine<br><br>Hetereocycles: Pyrimidine, Piperazine Ring<br><br>Indication: Erectile Dysfunction and Pulmonary Arterial Hypertension<br><br>Target Receptor: Phosphodiesterase 5 (PDE5).&nbsp;</div><div><br>Mechanism of Action: PDE5 is a key enzyme involved in the regulation of cGMP-specific signaling pathways in normal physiological processes such as smooth muscle contraction and relaxation. For this reason, inhibition of the enzyme can alter those pathophysiological conditions associated with a lowering cGMP level in tissues.<br><br>Role: Inhibitor</div><div>&nbsp;<br>Common Side Effects:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<br><br>Dermatologic: , Flushing&nbsp;<br>Gastrointestinal: Indigestion<br>Neurologic:&nbsp; Insomnia<br>Ophthalmic: Visual disturbance&nbsp;<br>Respiratory: Bleeding from nose, Nasal congestion ,Rhinitis&nbsp;<br><br></div><div>Serious Side Effects<br><br>Cardiovascular: Cardiovascular morbidity, Myocardial infarction, Sickle cell anemia with Vaso occlusive crisis<br>Ophthalmic: Non-arteritic ischemic optic neuropathy, Retinal hemorrhage&nbsp;<br>Otic: Decreased hearing, Sudden onset, Sudden hearing loss&nbsp;<br>Reproductive: Priapism, Prolonged erection of 🤬<br><br></div><div>&nbsp;</div><div><br><br><br><br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286858/291841b9f0ba6dc2228907a6394f5eca/Sildenafil_300.png" />
         <pubDate>2022-08-25 15:30:04 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271576398</guid>
      </item>
      <item>
         <title>Chandler Gandy</title>
         <author>cdgandy</author>
         <link>https://padlet.com/hoangle/ale/wish/2271596333</link>
         <description><![CDATA[<div>Assigned Drug: Methylphenidate<br><br>Structure: image attached<br><br>Functional Groups: ester, secondary amine, benzene ring<br><br>Heterocycles: piperidine<br><br>Indication: ADHD and Narcolepsy<br><br>Targets: Sodium-dependent dopamine transporter, 5-hydroxyltryptamine receptor, Sodium-dependent noradrenaline transporter<br><br>MOA:&nbsp; While its exact mechanism is unclear, methylphenidate (MPH) has been shown to act as a norepinephrine and dopamine reuptake inhibitor (NDRI), thereby increasing the presence of these neurotransmitters in the extraneuronal space and prolonging their action.<br><br>Role: Inhibitor<br><br>Common Side Effects:&nbsp;<br>Gastrointestinal- Decreased appetite, nausea, xerostomia</div><div>Nervous system-&nbsp; Headache including migraine; tension headache), insomnia (including initial insomnia), irritability<br><br>Serious Side Effects:</div><div>Cardiovascular events- acute myocardial infarctions [MI], sudden cardiac death, stroke, increased heart rate, and increased blood pressure<br>Growth suppression (pediatric) and Priapism Psychiatric/behavioral effects- pyschosis, mania symptoms<br><br>Sources: Lexicomp and Drug Bank<br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286300/dac3e721e794188ce9779f4b5b1a88c1/Methylphenidate_1.png" />
         <pubDate>2022-08-25 15:46:08 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271596333</guid>
      </item>
      <item>
         <title>Alaina Wigginton</title>
         <author>akwiggin</author>
         <link>https://padlet.com/hoangle/ale/wish/2271738727</link>
         <description><![CDATA[<div>1. Assigned Drug: Rosuvastatin<br><br>2. Structure: ^ shown above<br><br>3. Functional Groups: a Carboxylic acid, sulfonamide, alkene, halogenated benzene ring, and 2 secondary alcohols<br><br>4. Heterocycles: Pyrimidine<br><br>5. Indication: Familial hypercholesterolemia &amp; prevention of cardiovascular (Crestor only)<br><br>6. Target: 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)&nbsp;<br><br>7: MOA: Rosuvastatin is a selective inhibitor of HMG-CoA which is the rate-limiting enzyme in cholesterol synthesis. The lipid-modifying effects result from its capacity to upregulate hepatic LDL receptors enhancing uptake and catabolism of LDL as well as its activity of inhibiting hepatic synthesis of VLDL contributing to the reduction of VLDL and LDL particles.<br><br>8. Side effects: abdominal pain, myalgia, asthenia, headache<br><br>&nbsp;<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774221414/251a65f39771e237d7e5e92e2e2e47b0/1200px_Rosuvastatin_Formulae_V_1.png" />
         <pubDate>2022-08-25 17:33:01 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2271738727</guid>
      </item>
      <item>
         <title>Jessica Bihn</title>
         <author>jbihn1</author>
         <link>https://padlet.com/hoangle/ale/wish/2272108140</link>
         <description><![CDATA[<div>Assigned drug: Valsartan&nbsp;<br><br>Structure: image attached&nbsp;<br><br>Functional groups: carboxyl acid, amide, and secondary amine<br><br>Heterocycles: Tetrazole<br><br>Indications: Heart failure with reduced ejection fraction, chronic hypertension, and Post–myocardial infarction<br><br>Target: angiotensin II (AT2) receptors<br><br>MOA: Antagonism of the angiotensin II (AT2) receptors. It displaces angiotensin II from the AT1 receptor and produces its blood pressure-lowering effects by antagonizing AT1-induced vasoconstriction, aldosterone release, catecholamine release, arginine vasopressin release, water intake, and hypertrophic responses. This action results in a more efficient blockade of the cardiovascular effects of angiotensin II and fewer side effects than ACE inhibitors.<br><br>Role: antagonist&nbsp;<br><br>Indication: Valsartan is indicated for the treatment of hypertension to reduce the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It is also indicated for the treatment of heart failure and left ventricular dysfunction or failure after myocardial infarction when using an ACEI is not appropriate.&nbsp;<br><br>Side effects: (BBW) Fetal toxicity; (Significant) Hyperkalemia, Acute kidney injury; Dizziness, Increased blood urea nitrogen&nbsp;</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774284889/cc7dce6cbde41cc1e29936a989b1dcce/C677FBF9_611A_4A3E_B9C3_744B9EE7E7B1.png" />
         <pubDate>2022-08-26 01:13:25 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2272108140</guid>
      </item>
      <item>
         <title>Emma Russell </title>
         <author></author>
         <link>https://padlet.com/hoangle/ale/wish/2272115296</link>
         <description><![CDATA[<div>Assigned Drug: Pantoprazole<br><br>Structure: image attached&nbsp;<br><br>Functional Groups: Ether, Amines, Sulfoxide<br><br>Heterocycle: imidazole, pyridine, indole</div>]]></description>
         <enclosure url="https://gpatindia.com/wp-content/uploads/2020/10/pantoprazol-strcuture-768x355.png" />
         <pubDate>2022-08-26 01:20:15 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2272115296</guid>
      </item>
      <item>
         <title>Jennah Morris </title>
         <author>jjmorri2</author>
         <link>https://padlet.com/hoangle/ale/wish/2272118750</link>
         <description><![CDATA[<div>Assigned drug: Acyclovir<br><br>Structure: Image above<br><br>Functional Groups: alcohol, amine, ether<br><br>Heterocycle: imidazole<br><br>Indication: acute herpetic keratitis caused by Herpes Simplex Virus type 1 and 2<br><br>Targets: DNA Polymerase<br><br>MOA: stops replication of herpes viral DNA by competitive inhibition of viral DNA polymerase, incorporation into and termination of the growing viral DNA chain, and inactivation of the viral DNA polymerase<br><br>Side effects: Decreased hemoglobin, decrease in absolute neutrophil count, Pruritus, skin rash,&nbsp; Diarrhea, nausea, Thrombocytopenia, Increased serum bilirubin,&nbsp;</div><div><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286315/e9d904f4199af692956089699519938c/Acyclovir2.png" />
         <pubDate>2022-08-26 01:23:16 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2272118750</guid>
      </item>
      <item>
         <title>Madison Tullos</title>
         <author>mktullos</author>
         <link>https://padlet.com/hoangle/ale/wish/2272865893</link>
         <description><![CDATA[<div>Assigned Drug: Duloxetine&nbsp;<br><br>Structure: Attached image<br><br>Functional Groups: Naphthalene, Ether, Secondary Amine<br><br>Heterocycles: Thiophene&nbsp;<br><br>Indication: major depression<br><br>Target: Dopamine transporter<br><br>MOA: It is an inhibitor of serotonin and norepinephrine reuptake&nbsp; and a less active inhibitor of dopamine.&nbsp;<br><br>Role of the drug interaction with target:&nbsp;corticotropin releasing hormone receptor-1 antagonist <br><br>Side effects of Duloxetine:&nbsp;difficulties sleeping, dizziness, constipation, nausea, blurry vision, dry mouth </div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774151531/37cf6efab2f8a1fc27105947bc801f9a/1200px_Duloxetine_svg.png" />
         <pubDate>2022-08-26 16:18:00 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2272865893</guid>
      </item>
      <item>
         <title>Kenna Hutto</title>
         <author>khutto6</author>
         <link>https://padlet.com/hoangle/ale/wish/2272983798</link>
         <description><![CDATA[<div>Assigned Drug: Potassium Chloride<br><br>Structure: Image attached<br><br>Functional Group: Halogenated ion<br><br>Heterocycles: None<br><br>Indication: Diabetic ketoacidosis, hypokalemia, parenteral nutrition<br><br>Targets: Solute carriers<br><br>MOA: Potassium is the major cation of intracellular fluid and is essential for the conduction of nerve impulses in heart, brain, and skeletal muscle; contraction of cardiac, skeletal and smooth muscles<br><br>Role of drug in interaction: electrolyte supplement<br><br>Indication: Potassium chloride is used to replenish the potassium in the body. It is used to treat diabetic ketoacidosis, hypokalemia (low potassium), and used for parental nutrition<br><br>Side effects:&nbsp;<br>Common- diarrhea, flatulence, nausea, vomiting<br>Serious- cardiac arrest, hyperkalemia, abdominal pain, gastrointestinal ulcer<br><br><br><br></div>]]></description>
         <enclosure url="https://www.apexbt.com/media/diy/images/struct/B7289.png" />
         <pubDate>2022-08-26 18:18:09 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2272983798</guid>
      </item>
      <item>
         <title>Hosam Mohamed</title>
         <author>hm62069</author>
         <link>https://padlet.com/hoangle/ale/wish/2273174598</link>
         <description><![CDATA[<div><br>Assigned Drug: Amitriptyline&nbsp;<br><br>Structure: image above&nbsp;<br><br>Functional Groups: tertiary amine, 2 benzene rings, cycloheptane&nbsp;<br><br>Heterocycles: none<br><br>Indication: major depression or social anxiety<br><br>targets: 5-HT receptors 2A &amp; 1A, sodium-dependent noradrenaline transporter,&nbsp; and sodium-dependent serotonin transporter<br><br>MOA: The precise action of this tricyclic antidepressant is still not fully understood, but scientists believe that it inhibits the re-uptake of both norepinephrine &amp; serotonin. Amitriptyline contains a desipramine that is metabolized into nortriptyline which accounts for the majority of the norepinephrine reuptake inhibition. Hydroxy metabolites are also active as well and contribute to the down-regulation of limbic beta-receptors. Typical therapeutic concentrations are achieved in about 5-7 days.&nbsp;<br><br>Common Side effects: weight gain, constipation, xerostomia, dizziness, headache, somnolence, blurred vision.<br><br>Serious Side effects: cardiac dysrhythmia, electrocardiogram abnormal, myocardial infarction, prolonged QT interval, sudden cardiac death, agranulocytosis, hepatotoxicity, jaundice, neuroleptic malignant syndrome, seizure, depression, suicidal thoughts</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774287234/f1cde7817229699e9c7dd80bcac30aaa/amitriptyline.png" />
         <pubDate>2022-08-27 00:18:10 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273174598</guid>
      </item>
      <item>
         <title>Riya Patel</title>
         <author>riaapatel1298</author>
         <link>https://padlet.com/hoangle/ale/wish/2273208768</link>
         <description><![CDATA[<div>Assigned Drug: Valacyclovir<br><br>Structure: Above<br><br>Functional Groups: Amide group, ketonic group, ether group, methyl group, amino group<br><br>Heterocycles: Imidazole<br><br>Indication for use: herpes simplex virus 1, herpes simple virus 2, varicella-zoster virus.<br><br>Targets: Thymidine Kinase, DNA polymerase catalytic subunit<br>&nbsp;<br>MOA: Valacyclovir is converted to acyclovir, which is converted to its triphosphate from, acyclovir triphosphate (ACV-TP). ACV-TP competitively inhibits viral DNA polymerase, incorporates into and terminates the growing viral DNA chain, and inactivates of the virus DNA polymerase.&nbsp;<br>&nbsp;<br>Role: Antiviral Nucleosides<br><br>side effects: Headache, Nausea, Vomiting, Loss of strength and energy, Abdominal pain, Menstrual pain<br><br></div><div><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1780582761/4aad878a6f6b2e22b475eabbe81cb710/Valacyclovir_Structural_Formulae.png" />
         <pubDate>2022-08-27 01:54:42 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273208768</guid>
      </item>
      <item>
         <title>Lauron Chaney</title>
         <author>lechaney</author>
         <link>https://padlet.com/hoangle/ale/wish/2273284905</link>
         <description><![CDATA[<div>Assigned drug: Estradiol<br><br>Structure: Attached Image<br><br>Functional Groups: Phenol, Alcohol<br><br>Heterocycles: none<br><br>Indication: Breast cancer, metastatic; functional hypothalamic amenorrhea with low bone density; hormone therapy; hypoestrogenism;&nbsp;<br><br>Targets: Estrogen receptors<br><br>MOA: Estrogens are responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Estradiol is the principle intracellular human estrogen and is more potent than estrone and estriol at the receptor level; it is the primary estrogen secreted prior to menopause. Following menopause, estrone and estrone sulfate are more highly produced. Estrogens modulate the pituitary secretion of gonadotropins, luteinizing hormone, and follicle-stimulating hormone through a negative feedback system; estrogen replacement reduces elevated levels of these hormones in postmenopausal women.<br><br>Role: Agonist<br><br>Common Side Effects: anxiety, bloating, angioedema, headache, weight changes<br><br>Serious Side Effects: increased risk of endometrial cancer, cardiovascular risk (stroke and dvt), risk for breast cancer, </div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1300885215/7d305eca2ad14ae6c9644754414418d6/Estradiol.png" />
         <pubDate>2022-08-27 06:17:42 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273284905</guid>
      </item>
      <item>
         <title>Delaney Jackson</title>
         <author>dkjacks2</author>
         <link>https://padlet.com/hoangle/ale/wish/2273454930</link>
         <description><![CDATA[<div>Assigned Drug: Ondansetron<br><br>Structure: (image attached)<br><br>Functional Groups: Imine, Tertiary Amine, Ketone, Arene<br><br>Heterocycles: Imidazole<br><br>Indication: Nausea and vomiting associated with chemotherapy, radiotherapy, or operation&nbsp;<br><br>Target: 5-hydroxytryptamine-3 (5-HT3) receptor (a ligand-gated ion channel)<br><br>MOA: It antagonizes the 5-HT3-receptor which blocks serotonin, both peripherally on vagal nerve terminals and centrally in the chemoreceptor trigger zone.<br><br>Role: Antagonist<br><br>Common Side Effects:&nbsp;<br>Gastrointestinal - Constipation, Diarrhea<br>Neurologic - Headache<br>Respiratory - Hypoxia<br>Other - Fatigue, Malaise<br><br>Serious Side Effects:&nbsp;<br>Cardiovascular - Abnormal Electrocardiogram, Prolonged QT interval, Torsades de Pointes<br>Other - Serotonin syndrome</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286279/6050e0c0c1cb3c1db8e2bb8951001e6d/Ondansetron_Structure.png" />
         <pubDate>2022-08-27 16:32:24 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273454930</guid>
      </item>
      <item>
         <title>Rushali Shah</title>
         <author>rushalishah14</author>
         <link>https://padlet.com/hoangle/ale/wish/2273532650</link>
         <description><![CDATA[<div>Assigned Drug: Diltiazem<br><br>Structure: Image Attached<br><br>Functional Groups: tertiary amines, benzene, thioether, aldehyde, ketone<br><br>Heterocycles: none<br><br>Indications: Hypertension, angina pectoris, atrial fibrillation or atrial flutter, pulmonary arterial hypertension, nonsustained ventricular tachycardia or ventricular premature beats, supraventricular tachycardia<br><br>Target(s): cardiac and vascular smooth muscle<br><br>Mechanism of Action: Inhibits calcium ion from entering the “slow channels” or select voltage-sensitive areas of vascular smooth muscle and myocardium during depolarization; produces relaxation of coronary vascular smooth muscle and coronary vasodilation; increases myocardial oxygen delivery in patients with vasospastic angina.<br><br>Role of Drug in Interaction with Target: antagonist<br><br>Side Effects: conduction abnormalities, cutaneous hypersensitivity reactions, headache, fatigue, dizziness<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286307/c94d8dc9130b9c35e21261d39bdd6745/800px_Diltiazem_structure_svg.png" />
         <pubDate>2022-08-27 21:09:03 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273532650</guid>
      </item>
      <item>
         <title> Mary Wynne Tucker</title>
         <author>mtucker41</author>
         <link>https://padlet.com/hoangle/ale/wish/2273537654</link>
         <description><![CDATA[<div>Assigned Drug: Citalopram<br><br>Structure: Image attached<br><br>Functional Groups: tertiary amine, benzene<br><br>Heterocycles: Tetrahydrofuran<br><br>Indication: Aggressive behavior associated with dementia, binge eating disorder, generalized anxiety disorder, major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, social anxiety disorder, and vasomotor symptoms associated with menopause <br><br>Targets: Serotonin Transporter <br><br>MOA: A racemic bicyclic phthalane derivative, citalopram selectively inhibits serotonin reuptake in the presynaptic neurons and has minimal effects on norepinephrine or dopamine. Uptake inhibition of serotonin is primarily due to the <em>S</em>-enantiomer of citalopram. Displays little to no affinity for serotonin, dopamine, adrenergic, histamine, GABA, or muscarinic receptor subtypes.<br><br>Role: Selective Serotonin Reuptake Inhibitor&nbsp;<br><br>Side Effects:&nbsp;</div><ul><li><strong>Cardiovascular: </strong>Myocardial infarction, Prolonged QT interval, Torsades de pointes</li><li><strong>Hematologic: </strong>Hemorrhage, Abnormal</li><li><strong>Neurologic: </strong>Cerebrovascular accident </li><li><strong>Psychiatric: </strong>Suicidal thoughts, Suicide</li><li><strong>Other: </strong>Serotonin syndrome</li><li><strong>Dermatologic: </strong>Diaphoresis </li><li><strong>Gastrointestinal: </strong>Constipation, Diarrhea, Nausea, Vomiting, Xerostomia </li><li><strong>Neurologic: </strong>Dizziness, Headache, Insomnia, Sedated, Somnolence, Tremor</li><li><strong>Psychiatric: </strong>Agitation</li><li><strong>Reproductive: </strong>Disorder of 🤬</li><li><strong>Other: </strong>Fatigue</li></ul><div><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774287452/77667169113850dabb0fb534077e2dce/Citalopram.png" />
         <pubDate>2022-08-27 21:31:25 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273537654</guid>
      </item>
      <item>
         <title>Jessi Grove</title>
         <author>jngrove1</author>
         <link>https://padlet.com/hoangle/ale/wish/2273551094</link>
         <description><![CDATA[<div>Assigned Drug: Pravastatin<br><br>Structure: image attached<br><br>Functional Groups: Carboxylic acid, Secondary Alcohols, Ester, Cyclohexenes<br><br>Heterocycles: None<br><br>Indication: Prophylaxis for patients with clinically evident coronary heart disease and for Hypercholesterolemia (primary, heterozygous familial, familial type 3 hyperlipoproteinemia, hypertrigylceridemia)<br><br>Target: 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase<br><br>Mechanism of Action: Pravastatin is a competitive, reversible inhibitor of HMG-CoA reductase which is the rate-limiting enzyme for cholesterol synthesis. Pravastatin prevents the conversion of HMG-CoA into mevalonate (precursor for cholesterol) which clears circulating LDL and prevents the production of LDL by inhibiting its precursor.<br><br>Interaction with Target: Enzyme Inhibitor<br><br>Side Effects: rash, diarrhea, nausea and vomiting, musculoskeletal pain, headache, cough, upper respiratory infection, diabetes mellitus, pancreatitis, increased liver enzymes, liver failure, statin-associated autoimmune myopathy </div>]]></description>
         <enclosure url="https://upload.wikimedia.org/wikipedia/commons/thumb/d/d8/Pravastatin.svg/641px-Pravastatin.svg.png" />
         <pubDate>2022-08-27 22:39:17 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273551094</guid>
      </item>
      <item>
         <title>Jessica Wilson</title>
         <author>jmwilso6</author>
         <link>https://padlet.com/hoangle/ale/wish/2273558697</link>
         <description><![CDATA[<div><strong>Assigned Drug: </strong>Allopurinol<br><strong>Structure:</strong> Attached Image<br><strong>Functional Groups: </strong>Amide, Amine</div><div><strong>Heterocycles:</strong> Pyrazole, Pyrimidine<br><strong>Indications:</strong> Gout, Nephrolithiasis, Recurrent calcium or uric acid stones, Tumor lysis syndrome<br><strong>Target: </strong>xanthine dehydrogenase<br><strong>MOA: </strong>By metabolizing into oxypurinol, allopurinol inhibits xanthine oxidase and essentially stops the production of uric acid.<br><strong>Side Effects</strong>:<br>- Common: Maculopapular eruption, Pruritus (less than 1%)</div><div>- Serious: Drug reaction with eosinophilia and systemic symptoms, Rash (up to 3% ), Stevens-Johnson syndrome (less than 1% ), Toxic epidermal necrolysis (less than 1% ); Agranulocytosis, Aplastic anemia, Eosinophil count raised, Myelosuppression, Thrombocytopenia (0.6% ); Granulomatous hepatitis (less than 1% ), Hepatic necrosis (less than 1% ), Hepatotoxicity; Hypersensitivity reaction; Renal failure (less than 1% )</div><div><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286092/6bfc84cbf7ab60bf03fe13bad1a6cf19/Allopurinol_300.png" />
         <pubDate>2022-08-27 23:20:50 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273558697</guid>
      </item>
      <item>
         <title>Alandria Eppenger</title>
         <author>landraepp12</author>
         <link>https://padlet.com/hoangle/ale/wish/2273617937</link>
         <description><![CDATA[<div>Assigned Drug: Escitalopram<br><br>Functional Groups: Amine, Tetrahydrofuran, nitrile, ether, fluorobenzene<br><br>Heterocycles: None<br><br>Indications: Depression and generalized anxiety disorder<br><br>Drug Target: serotonin (5-HT)<br><br>MOA: The S-enationmer of racemic citalopram, is presumed to be linked to potentiation on serotonergic activity in the CNS result from its inhibition of CNS neuronal reuptake of serotonin.&nbsp;<br><br>Side Effects: Include but are not limited to:<br>Dizziness&nbsp;<br>Nausea<br>Diarrhea and/or constipation<br>Dry Mouth<br>Insomnia<br>Sweating profusely&nbsp;<br>Flu-Like Symptoms<br>Runny Nose<br>Congestion<br>Fatigue<br>Most severe side effects include: mood swings, seizures, bleeding in vomit or while coughing, etc. </div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1297144539/db1be8855f816393d69849d430546bd3/Screen_Shot_2022_08_27_at_10_23_59_PM.png" />
         <pubDate>2022-08-28 03:28:45 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273617937</guid>
      </item>
      <item>
         <title>Samuel Lyles</title>
         <author>sdlyles1</author>
         <link>https://padlet.com/hoangle/ale/wish/2273866165</link>
         <description><![CDATA[<div>Assigned Drug: Cetirizine<br><br>Structure: Image attached<br><br>Functional Groups: Carboxylic acid, ether<br><br>Heterocycles: Piperazine<br><br>Indications: seasonal allergies, chronic and acute idiopathic urticaria, atopic dermatitis, ocular pruritis<br><br>Target: Histamine H1 receptor<br><br>MOA: Antagonist of the histamine H1 receptor which helps to limit inflammatory responses</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286088/e198d18a033caccea0ba9d8f79e54653/Cetirizine_structure.png" />
         <pubDate>2022-08-28 16:57:24 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273866165</guid>
      </item>
      <item>
         <title>Rachel Robbins</title>
         <author>rachelrobbins18</author>
         <link>https://padlet.com/hoangle/ale/wish/2273886215</link>
         <description><![CDATA[<div>Assigned Drug: Albuterol&nbsp;<br><br>Structure: image attached&nbsp;<br><br>Functional Groups: Primary Alcohol (1), Secondary Alcohol (1), Secondary Amine (1), Phenol (1)<br><br>Heterocycles: N/A<br><br>Indication: Prevention/treatment of difficulty breathing, wheezing, shortness of breath, coughing and chest tightness caused by lung disease (asthma and chronic obstructive pulmonary disease)<br><br>Target(s): Beta-2 adrenergic receptors<br><br>Mechanism of Action: Acts on the beta-2 receptors to relax bronchial smooth muscle. Inhibits the release of immediate hypersensitivity mediators from cells.<br><br>Interaction with Target: agonist<br><br>Indication: asthma, bronchospasm due to anaphylaxis, chronic obstructive pulmonary disease, hyperkalemia&nbsp;<br><br>Side Effects:&nbsp;cardiovascular effects, CNS effects, Paradoxical bronchospasm </div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774257034/7bfda388c2702af818f22c909140d0d3/albuterol_chemical_structure.gif" />
         <pubDate>2022-08-28 17:57:19 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273886215</guid>
      </item>
      <item>
         <title>Mieyah Garrett</title>
         <author>magarre2</author>
         <link>https://padlet.com/hoangle/ale/wish/2273926250</link>
         <description><![CDATA[<div>-Assigned drug: Sitagliptin<br><br>-Functional Groups: benzene, amine (primary and tertiary), carbonyl, akyl halide, amide<br><br>-Heterocycle: trizole<br><br>-Indication: Diabetes Type II<br><br>-Target(s): Dipeptidyl peptidase (DDP-4) enzyme&nbsp;<br><br>-Mechanism of Action: Sitagliptin inhibits DDP-4. DDP-4 slows the production of hormones that decreases blood glucose levels, while insulin synthesis is increased.<br><br>-Role of the drug in interaction with the target: enzyme inhibitor<br><br>-Indication: (Diabetes mellitus, type 2, treatment) As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, as monotherapy or combination therapy.</div><div><br></div><div>-Side effects:<br>• Headache</div><div>• Signs of a common cold</div><div>• Nose or throat irritation<br>• Kidney problems like unable to pass urine</div><div>• Low blood sugar<br>• Pancreas problems (pancreatitis) like severe stomach pain<br>• A severe skin reaction</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286390/c0267940b9b3df4429ac7adfd6baa53c/Sitagliptin_300.png" />
         <pubDate>2022-08-28 19:53:45 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273926250</guid>
      </item>
      <item>
         <title>Brandon Ashmore</title>
         <author>bgashmor</author>
         <link>https://padlet.com/hoangle/ale/wish/2273942984</link>
         <description><![CDATA[<div>Assigned Drug: Metformin<br><br>Functional Groups: primary and tertiary amines (asymmetrical biguanide)<br><br>Heterocycles: None<br><br>Indicated for Type 2 Diabetes Mellitus&nbsp;<br><br>Targets: mitochondrial complex 1, glucagon-like peptide 1 (GLP-1)<br><br>Mechanism of action: Exact mechanism of action is unknown. Metformin decreases the production of glucose in the liver, decreases the absorption of glucose in the intestine, and increases the uptake of peripheral glucose to improve insulin sensitivity.<br><br>Major side effects include lactic acidosis (Black Box Warning), GI effects (diarrhea, nausea, vomiting, flatulence, abdominal pain), and vitamin B12 deficiency (leading to anemia and neuropathy). Other possible side effects include chest discomfort, flushing, palpitations, hypoglycemia, chills, dizziness, headaches, muscle pain, trouble breathing, flu-like symptoms, and upper respiratory tract infections.<br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286069/e4b638ba256ddd1c5c16d1c78f55822c/Chemical_structure_of_Metformin.png" />
         <pubDate>2022-08-28 20:45:48 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273942984</guid>
      </item>
      <item>
         <title>Matt Burchfield</title>
         <author>mmburchf</author>
         <link>https://padlet.com/hoangle/ale/wish/2273963934</link>
         <description><![CDATA[<div>Assigned Drug: Glipizide<br><br>Functional groups: Benzene, Amide, Sulfonylurea, Cyclohexane<br><br>Heterocycles: Pyrazine<br><br>Indication: Type 2 Diabetes<br><br>Target: Pancreatic Beta Cells&nbsp;<br><br>MOA: Glipizide sparks a release, from the pancreas, of insulin. There is a decrease in the amount of glucose that is removed by the liver. Peripheral target sites acquire an increase in insulin sensitivity.&nbsp;<br><br>Side effects:&nbsp;<br>Hypoglycemia, Abdominal pain, constipation, diarrhea, dyspepsia, flatulence, nausea, vomiting, eczema, erythema of skin, maculopapular rash, morbilliform rash, pruritus, urticaria, dizziness, drowsiness, headache, nervousness, tremor, increased lactate dehydrogenase, increased serum alkaline phosphatase, increased serum aspartate aminotransferase, increased blood urea nitrogen, increased serum creatinine, skin rash, hyponatremia, agranulocytosis, aplastic anemia, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia, cholestatic jaundice, hepatic injury, hepatic porphyria, jaundice, myopathy, disulfiram-like reaction&nbsp;<br><br></div><div><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774147878/bdfd11600ab5b6f55a81aaffd88d167d/Glipizide_Structure.png" />
         <pubDate>2022-08-28 21:49:41 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273963934</guid>
      </item>
      <item>
         <title>Colby Calloway</title>
         <author>ckcallow</author>
         <link>https://padlet.com/hoangle/ale/wish/2273967096</link>
         <description><![CDATA[<div>Assigned Drug: Furosemide<br><br>Structure: Image attached<br><br>Functional groups:&nbsp; amine, alkyl halide, carboxylic acid<br><br>Heterocycle:&nbsp; Oxole<br><br>Indication:&nbsp; treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.<br><br>Target:&nbsp; SLC12A1, CA2, GPR35<br><br>MOA:&nbsp; promotes diuresis by blocking tubular reabsorption of sodium and chloride in the proximal and distal tubules, as well as in the thick ascending loop of Henle.<br><br>Role of drug interaction with target:  inhibits the luminal Na-K-Cl cotransporter.<br><br>Side effects of Furosemide:  peeing more than normal, feeling thirtsy, dry mouth, headaches, feeling confused or dizzy, feeling of being sick (nausea or vomiting).</div><div><br></div><div><br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286506/5bf8cd423358c2e83fc7fd870722e791/Furosemide.png" />
         <pubDate>2022-08-28 22:00:44 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273967096</guid>
      </item>
      <item>
         <title>Kristen Stivers</title>
         <author>kgstiver</author>
         <link>https://padlet.com/hoangle/ale/wish/2273975641</link>
         <description><![CDATA[<div><strong><em>Assigned Drug:</em></strong> Diclofenac<br><strong><em>Structure:</em></strong> Image attached<br><strong><em>Functional Groups:</em></strong> carboxylic acid, secondary amine, and benzene ring <br><strong><em>Heterocycles:</em></strong> None<br><strong><em>Indication: </em></strong>provides anti-inflammatory and analgesic effects in the symptomatic treatment of osteoarthritis, rheumatoid arthritis,&nbsp; mild to moderate acute pain, and ankylosing spondylitis, used in the acute treatment of migraine attacks with or without aura and in the management of primary dysmenorrhea symptoms<br><strong><em>Target:</em></strong> COX-1 and COX-2<br><strong><em>MOA:</em></strong> inhibits the synthesis of prostaglandins by through inhibition of cyclooxygenases (COX-1 and COX-2); other exact mechanisms have yet to be established.<br><strong>Interaction Role: </strong>COX-1 and COX-2 inhibitor<br><strong>Indication: </strong>Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis<br><strong>Side Effects: </strong>dizziness, headache, edema, abdominal pain, constipation, diarrhea, nausea/vomiting, dyspepsia, pain in extremities, skin hypersensitivity reactions, GI inflammation, ulcers, and bleeding</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774288067/317dd2e441d34e0ff3dede972eff4b05/Diclofenac_300.png" />
         <pubDate>2022-08-28 22:28:35 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2273975641</guid>
      </item>
      <item>
         <title>Jessica Konys</title>
         <author>jmkonys</author>
         <link>https://padlet.com/hoangle/ale/wish/2274071310</link>
         <description><![CDATA[<div>Assigned Drug: Lorazepam<br>Structure: image attached&nbsp;<br>Functional Groups: Halogen, Amide, secondary alcohol<br>Heterocycles: none<br>Indication: treatment of anxiety, treatment of status epilepticus<br>Target: GABA-A receptor<br>MOA:&nbsp;Binds to postsynaptic receptors on GABA neuron and inhibits, resulting in increased membrane permeability to Cl- ions. The shift in Cl- ions results in hyperpolarization and stabilization.</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286447/8ac1105c2382d0058b11aacca3a64969/lorazepam_structure.png" />
         <pubDate>2022-08-29 01:03:26 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274071310</guid>
      </item>
      <item>
         <title>Taylor Shamblin </title>
         <author>tsshambl</author>
         <link>https://padlet.com/hoangle/ale/wish/2274087824</link>
         <description><![CDATA[<div>1) Clopidogrel (Plavix)&nbsp;</div><div>2) Structure: Posted&nbsp;<br>3) Functional Groups: Circled<br>4) Heterocycles: Circled<br>5) Target: ADP Receptor -- P2Y12<br>6) Mechanism of Action:<br>While active, Clopidogrel irreversibly blocks P2Y12 component of ADP receptors on platelet surface -- prevents activation of GPIIIb/IIIa receptor complex (decrease platelet aggregation).&nbsp;<br>7) Interaction Role:&nbsp;P2Y12 Antagonist<br>8) Indication:&nbsp;Acute Coronary Syndrome (myocardial infarction)<br>9) Side Effects: Vomiting up Blood, Blood in urine, Bleeding from gums, abnormal vaginal bleeding, random bruising, Fatigue, tachycardia, confusion, hunger, sweating </div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774287459/27b5b54d9c6bef668a3982d4576ae1fd/IMG_0005.jpg" />
         <pubDate>2022-08-29 01:19:37 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274087824</guid>
      </item>
      <item>
         <title>Camille Culp</title>
         <author>bcculp</author>
         <link>https://padlet.com/hoangle/ale/wish/2274093283</link>
         <description><![CDATA[<div>Assigned Drug:&nbsp; benztropine<br><br>Functional Groups:&nbsp; two benzenes, a tertiary amine, and ether<br><br>Heterocycles:&nbsp; pyrrolidine<br><br>Indication: drug-induced extrapyramidal symptoms and parkinsonism&nbsp;<br><br>Target: cholinergic receptors&nbsp;<br><br>MOA:&nbsp; Possesses both anticholinergic and antihistaminic effects. antagonizes the effect of acetylcholine to decrease imbalance of acetylcholine and dopamine&nbsp;<br><br>Interaction with receptor:&nbsp; inhibitor&nbsp;<br><br>Side Effects:  tachycardia, confusion, depression, skin rash, constipation, nausea, dysuria, and blurred vision<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286325/a8768965cb1aae42f528b022fb94e2c1/image.png" />
         <pubDate>2022-08-29 01:24:50 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274093283</guid>
      </item>
      <item>
         <title>Trevor Bures</title>
         <author>tdbures</author>
         <link>https://padlet.com/hoangle/ale/wish/2274127469</link>
         <description><![CDATA[<div>Assigned Drug: Warfarin<br>Structure: Image Attached<br>Functional Groups: Ketone, Ester, Secondary Alcohol<br>Heterocycles: 2H Chromene<br>Indications: Cardiac, Myocardial infection, Atrial fibrillation or flutter, Stress cardiomyopathy, Stroke or transient is chemical attack, Valvular, etc.<br>Target: VKORC1<br>MoA: Hepatic synthesis of coagulation factors II, VII, IX, and X, as well as proteins C and S, requiring vitamin K. Changes vitamin K from active form to inactive form.<br>Role: Antagonist<br>Indication: Adjunct to reduce risk of systemic embolism after myocardial infarction. Prophylaxis and treatment of thromboembolic disorders and embolic complications arising from atrial fibrillation or cardiac valve replacement.<br>Side Effects: Bleeding like vomiting blood or vomit that looks like coffee grounds; coughing up blood; blood in the urine; black, red, or tarry stools; bleeding from the gums; abnormal vaginal bleeding; bruises without a reason or that get bigger; or any severe or persistent bleeding, Kidney problems like unable to pass urine, blood in the urine, change in amount of urine passed, or weight gain, Weakness on 1 side of the body, trouble speaking or thinking, change in balance, drooping on one side of the face, or blurred eyesight, Swelling, warmth, numbness, change of color, or pain in a leg or arm, Chest pain, Severe dizziness, Passing out, Swelling. Severe headache, Skin discoloration to black or purple, Body temperature change, Pain, Severe loss of strength and energy, Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1783941982/778f2b28fae2953bb286189f95e30dd9/Warfarin.png" />
         <pubDate>2022-08-29 01:59:12 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274127469</guid>
      </item>
      <item>
         <title>Hayden Blanton</title>
         <author>hhblanto</author>
         <link>https://padlet.com/hoangle/ale/wish/2274184982</link>
         <description><![CDATA[<div>Assigned Drug: Metoprolol<br>Structure: Attached<br>Functional Groups: Ethers, Secondary Alcohol, Secondary Amine, Isopropyl, Benzene ring<br>Heterocycles: None<br>Indications: angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension<br>Targets: Beta 1/2 Adrenergic receptors<br>MOA: Inhibitor of Beta 1/2 Adrenergic receptors in cardiac cells. It lowers cardiac output by producing negative chronotropic and inotropic effects without presenting activity toward membrane stabilization or intrinsic sympathomimetics.<br>Role: Antagonist<br>Indication: Angina, Heart failure, Myocardial infarction, Atrial fibrillation, Atrial flutter and Hypertension.<br><br>Common Side Effects:&nbsp;<br>Feeling dizzy, tired, or weak<br>Diarrhea, upset stomach, or throwing up<br><br>Serious Side Effects:<br>Low mood (depression)<br>Very bad dizziness or passing out<br>Chest pain that is new or worse<br>An abnormal heartbeat that is new or worse<br>Slow heartbeat<br>Shortness of breath, a big weight gain, or swelling in the arms or legs</div><div><br>Allergic Side effects:<br>Rash<br>Hives<br>Itching<br>Red<br>Swollen<br>Blistered<br>Peeling skin with or without fever<br>Wheezing<br>Tightness in the chest or throat<br>Trouble breathing<br>Swallowing or talking<br>Unusual hoarseness<br>Swelling of the mouth, face, lips, tongue, or throat.<br><br></div><div><br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286484/94cd74bb0457db165098ad6eabb4de8a/Screen_Shot_2022_08_28_at_9_27_40_PM.png" />
         <pubDate>2022-08-29 02:53:16 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274184982</guid>
      </item>
      <item>
         <title>Makaila Handy</title>
         <author>mthandy</author>
         <link>https://padlet.com/hoangle/ale/wish/2274224678</link>
         <description><![CDATA[<div>Assigned Drug: Ramipril<br><br>Structure: Image Attached<br><br>Functional Groups: One amide, one carboxylic acid, and one aromatic.<br><br>Heterocycle: None<br><br>Indication: Hypertension, Reduction in the risk of Myocardial Infarction, Stroke, and death from Cardiovascular Causes, Heart Failure Post-Myocardial Infarction<br><br>Target: Ramipril is an ACE inhibitor used for the management of hypertension and the reduction of cardiovascular mortality following myocardial infarction in hemodynamically stable patients with clinical signs of congestive heart failure.<br><br>Mechanism of Action: Ramipril inhibits the RAAS system by binding to and inhibiting ACE thereby preventing the conversion of angiotensin I to angiotensin II. As plasma levels of angiotensin II fall, less activation of the G-protein coupled receptors angiotensin receptor I&nbsp; and angiotensin receptor II occurs.<br><br>Common Side Effects:<br>-A dry, tickly cough that does not get better<br>-Feeling dizzy or lightheaded, especially when you stand up or sit up quickly<br>-Headaches<br>-Diarrhea<br>-Being sick (vomiting)<br>-A mild skin rash<br>-Blurred vision<br><br>Serious Side Effects:<br>-Swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs<br>-Hoarseness<br>-Difficulty breathing or swallowing<br>-Yellowing of the skin or eyes<br>-Fever, sore throat, chills, and other signs of infection<br>-Lightheadedness<br>-Fainting</div><div><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286197/d416435d638e178eea5aea49121539f6/Makaila_Handy_Image.PNG" />
         <pubDate>2022-08-29 03:37:23 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274224678</guid>
      </item>
      <item>
         <title>Leah Hughes</title>
         <author>lhughes132</author>
         <link>https://padlet.com/hoangle/ale/wish/2274232105</link>
         <description><![CDATA[<div>Assigned Drug: Alfuzosin&nbsp;<br>Structure: Image Attached&nbsp;<br>Functional Groups: amines, ether&nbsp;<br>Heterocycles: tetrahydrofuran<br>Indication: for the symptomatic treatment of benign prostatic hyperplasia (BPH) and the treatment of erectile dysfunction (ED)<br>Target: Selective Antagonist at Alpha-1 Receptors<br>Mechanism of Action: Alfuzonsin works as a blockage at the Alpha-1 receptors. When these receptors are blocked, it causes a relaxation of the smooth muscles along the neck of the bladder and prostate. This reduces the amount of pressure placed on the urethra by BPH or ED and improves the quality of urine flow.<br>Role of Drug: Alfuzosin works as an enzyme inhibitor at the Alpha-1 adrenergic receptors.&nbsp;<br>Side Effects: tiredness, headache, runny/stuffy nose, pain, stomach pain, heartburn, constipation, nausea</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774292748/111cb09e8767a9ca06f679d0c9dde5b1/Alfuzosin.png" />
         <pubDate>2022-08-29 03:46:43 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274232105</guid>
      </item>
      <item>
         <title>Joh&#39;nis Randall</title>
         <author></author>
         <link>https://padlet.com/hoangle/ale/wish/2274267594</link>
         <description><![CDATA[<div>Assigned Drug: Denosumab<br><br>Functional Groups: arene, benzine ring, alkene, amine (primary and tertiary),  carbonyl, enamine, carboxamide<br><br>Heterocycle: pyrrole</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286116/2b67115c350133add0372b841f00c19b/Denosumab.png" />
         <pubDate>2022-08-29 04:30:58 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274267594</guid>
      </item>
      <item>
         <title></title>
         <author>sarceov</author>
         <link>https://padlet.com/hoangle/ale/wish/2274289878</link>
         <description><![CDATA[<div>Assigned Drug : Atorvastatin<br><br>Structure : image<br><br>Functional groups : Carboxylic acid, aromatic amine, ketone<br><br>Heterocycle : Pyrrole<br><br>Target : 3-hydroxy-3-methylglutaryl<br><br>Indication : Hypertriglyceridemia and adults with hyperlipidemia&nbsp;<br><br>MOA : Inhibits 3-hydroxy-3-methylglutaryl coenzyme A&nbsp; (HMG-CoA) reductase which is a rate limiting enzyme in cholesterol synthesis.&nbsp;<br><br>Side Effects : Diarrhea, nausea, joint paint, sore throat, having trouble sleeping, stuffy nose.&nbsp;<br><br>Role of drug in interaction : Enzyme inhibitor (inhibits coenzyme A (HMG-CoA) reductase)</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286706/589d5df082c8386205de8b9a10369772/image.png" />
         <pubDate>2022-08-29 04:54:18 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274289878</guid>
      </item>
      <item>
         <title>Colt Moore</title>
         <author>cdmoore3</author>
         <link>https://padlet.com/hoangle/ale/wish/2274338038</link>
         <description><![CDATA[<div>Assigned Drug: Bupropion<br>Structure: Image Attached<br>Functional Groups: Amines &amp; Amine Salts,Halides,Ketones &amp; Ketals<br>Heterocycles: none<br>Indication: Antidepressant<br>Target(s): Sodium-dependent dopamine transporter,<br>Sodium-dependent noradrenaline transporter<br>Mechanism of Action: Bupropion is a norepinephrine/dopamine-reuptake inhibitor (NDRI) that exerts its pharmacological effects by weakly inhibiting the enzymes involved in the uptake of the neurotransmitters norepinephrine and dopamine from the synaptic cleft, therefore prolonging their duration of action within the neuronal synapse and the downstream effects of these neurotransmitters.<br>Interaction: Sodium-dependent dopamine transporter inhibitor,<br>Sodium-dependent noradrenaline transporter inhibitor<br>Indication: major depressive disorder, seasonal affective disorder, smoking cessation<br>Side effects: activation of mania or hypomania, insomnia, anxiety, agitation, angle-closure glaucoma, seizure, suicidal thinking and behavior.</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774291432/358b2ffda6f6fd1776232f461b0d4df9/bupropion.png" />
         <pubDate>2022-08-29 05:50:21 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274338038</guid>
      </item>
      <item>
         <title>Colson Sanders</title>
         <author>cgsande2</author>
         <link>https://padlet.com/hoangle/ale/wish/2274816494</link>
         <description><![CDATA[<div>Assigned Drug: Ergocalciferol<br>Structure: Attached<br>Functional Groups: triene, hydroxyl <br>Heterocycles: none<br><br><br>Indication: <strong>for the treatment of hypoparathyroidism, refractory rickets, and familial hypophosphatemia</strong>.<br><br>Target: Vitamin D response elements<br><br><br>MOA: <strong>mobilization and accretion of calcium and phosphorus in the bone, absorption of calcium and phosphorus in the intestine, and reabsorption of calcium and phosphorus in the kidney</strong>.<br><br>Role of drug interaction with target: mobilization and accretion of calcium and phosphorus in the bone, absorption of calcium and phosphorus in the intestine, and reabsorption of calcium and phosphorus in the kidney<br><br>Side Effects: Overdosage with this agent is reported to produce hypervitaminosis characterized by hypercalcemia, renal impairment, calcification of soft tissues, a decline in the rate of linear growth and increase in bone mineralization</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286058/a5a867c9e570164e53a73568641d6e5f/image.png" />
         <pubDate>2022-08-29 14:24:34 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2274816494</guid>
      </item>
      <item>
         <title>Antoinette Davenport</title>
         <author>addaven1</author>
         <link>https://padlet.com/hoangle/ale/wish/2275054143</link>
         <description><![CDATA[<div>Assigned Drug: Fluticasone<br><br>Structure: Image Attached<br><br>Functional Groups: Ester, and thioester<br>Heterocycles: None<br><br>Indication: Management of seasonal and perennial allergic rhinitis and treatment of chronic rhino sinusitis<br><br>Drug Class: Corticosteroids<br><br>Mechanism of Action: Fluticasone belongs to a group of corticosteroids which utilizes a fluorocarbothioate ester linkage at the 17 carbon position; extremely potent vasoconstrictive and anti-inflammatory activity<br><br>It is an agonist at the glucocorticoid receptor<br><br>Hepatic via CYP3A4 to 17 beta-carboxylic acid (negligible activity)<br><br>Hepatic function impairment: Accumulation of fluticasone in plasma may occur in patients with hepatic impairment.<br><br>Some side effects may include headache, nausea, vomiting, cough, stinging, and sneezing</div><div><br><br><br><br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774288280/7ccb2b94355a90e744d2c110f24bce8a/image.png" />
         <pubDate>2022-08-29 17:13:07 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2275054143</guid>
      </item>
      <item>
         <title>Nolan Yates</title>
         <author>nryates</author>
         <link>https://padlet.com/hoangle/ale/wish/2275680643</link>
         <description><![CDATA[<div>Assigned drug: Dutasteride<br>Structure: image attached<br>Functional groups:&nbsp;Benzene, Halogenated compounds, Ketone, Amide<br>Heterocycles: none</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774286150/b4144cf3f807e854f60d8a4c4ee86813/Dutasteride_300x300.png" />
         <pubDate>2022-08-30 03:59:15 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2275680643</guid>
      </item>
      <item>
         <title>Dakota Jones</title>
         <author>ddjones3</author>
         <link>https://padlet.com/hoangle/ale/wish/2318249596</link>
         <description><![CDATA[<div>-Assigned Drug: Spironolactone<br>-Structure: attached image<br>-Functional Groups: Ketone, Ester functionality that is the lactone heterocycle, Carbon double bonds, Ketone attatched to cyclic structure, Methyl<br>Heterocycles: Lactone<br><br>(could not figure out how to edit my old one, so I copied and pasted my old post to my now new updated post)<br><br>-indication: hypertension, heart failure, ascites due to cirrhosis of liver-edema, primary hyperaldosteronism, and edema-nephrotic syndrome<br>-target: mineralocorticoid (aldosterone) receptor antagonist<br>-MOA: renal competitive aldosterone antagonist, so it inhibits effect of aldosterone in the body. It antagonizes the aldosterone-dependent sodium-potassium exchange site in kidneys, decreasing excretion of potassium and increasing secretion of water and sodium.<br><br>-side effects:<br>Gynecomastia and Hyperkalemia are the most significant common side effects to consider. Other common side effects include diarrhea, nausea, vomiting, somnolence, erectile dysfunction, and disordered mensuration. <br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1774287791/229668a3ca6025af9567a8e53d93ae2b/Screen_Shot_2022_09_28_at_3_34_15_PM.png" />
         <pubDate>2022-09-28 20:46:49 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2318249596</guid>
      </item>
      <item>
         <title>Delancy Anderson</title>
         <author>delancyea</author>
         <link>https://padlet.com/hoangle/ale/wish/2318277219</link>
         <description><![CDATA[<div>Assigned drug: levothyroxine<br><br></div><div>Functional groups: Phenolic –OH group, halide, ether, primary amine, carboxylic acid<br><br></div><div>Heterocycles:&nbsp;phenol<br><br></div><div>Indications: primary, secondary, and tertiary hypothyroidism , Myxedema coma and Thyroid stimulating hormone suppression therapy-Pituitary<br><br></div><div>Targets: TRα1, TRβ1<br><br></div><div>MOA: “Triiodothyronine (T3) and levothyroxine (T4) diffuse into the cell nucleus and bind to thyroid receptor proteins attached to DNA. This hormone nuclear receptor complex activates gene transcription and synthesis of messenger RNA and cytoplasmic proteins. The physiological actions of thyroid hormones are produced predominantly by T3, the majority of which (approximately 80%) is derived from T4 by deiodination in peripheral tissues” (Micromedex)</div><ul><li>[8] Product Information: Levothyroxine sodium intravenous injection, levothyroxine sodium intravenous injection. Fresenius Kabi USA LLC (per FDA), Lake Zurich, IL, 2019.</li></ul><div><br>Interaction: It is the agonist of Thyroid hormone receptor alpha and beta.<br><br>Indications: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. It is also indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.<br><br>Side effects:</div><ul><li>weight gain or loss</li><li>headache</li><li>vomiting</li><li>diarrhea</li><li>changes in appetite</li><li>fever</li><li>changes in menstrual cycle</li><li>sensitivity to heat</li><li>hair loss</li><li>joint pain</li><li>leg cramps</li></ul><div><br><br></div>]]></description>
         <enclosure url="https://file.medchemexpress.com/product_pic/hy-18341.gif" />
         <pubDate>2022-09-28 21:17:12 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2318277219</guid>
      </item>
      <item>
         <title>Emma Russell </title>
         <author>ekrusse1</author>
         <link>https://padlet.com/hoangle/ale/wish/2318283510</link>
         <description><![CDATA[<div>Assigned Drug: Pantoprazole<br><br>Structure: image attached <br><br>Functional Groups: Ether, Amines, Sulfoxide<br><br>Heterocycle: imidazole, pyridine, indole<br><br>Indication: gastroesophageal reflux disease<br><br>Targets: H<sub>2</sub>-receptor antagonists&nbsp;<br><br>Mechanism of Action: Proton pump inhibitor, suppresses gastric acid secretion by inhibiting the parietal cell H+/K+ ATP pump<br><br>Side Effects:&nbsp;<br>-Cutaneous and systemic lupus erythematosus</div><div>-Enteric infections</div><div>-Fractures</div><div>-Fundic gland polyps</div><div>-Hypersensitivity</div><div>-Hypomagnesemia</div><div>-Interstitial nephritis</div><div>-Vitamin B12 deficiency</div><div>​</div>]]></description>
         <enclosure url="https://file.medchemexpress.com/product_pic/hy-17507a.gif" />
         <pubDate>2022-09-28 21:25:01 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2318283510</guid>
      </item>
      <item>
         <title>Jimiah Campbell</title>
         <author></author>
         <link>https://padlet.com/hoangle/ale/wish/2323065663</link>
         <description><![CDATA[<div>Tramadol<br>Indications: pain management<br>Targets: μ-opiate receptors<br>Mechanism of action: μ-opiate receptors binding by tramadol and active metabolite. CNS causes inhibition of ascending pain pathways which alters the perception of and response to pain. The reuptake of norepinephrine and serotonin is inhibited, which helps with pain relief<br>This drug doesn't necessarily have a defined mechanism of action, but it does inhibit neurotransmitters - norepinephrine and epinephrine, which are believed to contribute to its pain relieving abilities. As of now, it is classified as a non-controlled analgesic.<br>Indications: chronic pain<br>&nbsp;- Off-label: premature 🤬<br>Side effects include:<br>• Feeling dizzy, sleepy, tired, or weak</div><div>• Constipation, diarrhea, throwing up, or upset stomach</div><div>• Dry mouth</div><div>• Headache</div><div>• Itching</div><div>• Trouble sleeping</div><div>• Flushing</div><div>• Sweating a lot</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1827144167/63f4dac04469e5d9fe1f24ff5d9a8097/Chemical_structure_of_Tramadol_HCL.png" />
         <pubDate>2022-10-03 02:29:27 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2323065663</guid>
      </item>
      <item>
         <title>Will Lambert</title>
         <author>williamlambo</author>
         <link>https://padlet.com/hoangle/ale/wish/2323117780</link>
         <description><![CDATA[<div>Assigned Drug: Omalizumab<br><br>Structure: Attached<br><br>Indication: Asthma / Chronic Spontaneous Urticaria / Nasal Polyps<br><br>Target Receptor: Immunoglobulin E (IgE)<br><br>Mechanism of Action: Omalizumab is an IgG monoclonal antibody which inhibits IgE binding to the high-affinity IgE receptor on mast cells and basophils. By decreasing bound IgE, the activation and release of mediators in the allergic response is limited. Long-term treatment in patients with allergic asthma showed a decrease in asthma exacerbations and corticosteroid usage.<br><br>Common Side Effects: Bleeding, blistering, burning, coldness, body aches, flu-like symptoms, congestion, dryness of throat, headache, hoarseness, leg pain, stuffy/runny nose</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1772391046/de9da0cb3da344123c5e83c04c35640c/Omalizumab_structure_Omalizumab_is_a_recombinyant_humanized_monoclonal_antibody_composed.png" />
         <pubDate>2022-10-03 03:44:11 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2323117780</guid>
      </item>
      <item>
         <title>Joh&#39;nis Randall</title>
         <author>jdrandal</author>
         <link>https://padlet.com/hoangle/ale/wish/2323142728</link>
         <description><![CDATA[<div>Assigned Drug: Denosumab<br><br>Functional Groups: arene, benzine ring, alkene, amine (primary and tertiary), carbonyl, enamine, carboxamide<br><br>Heterocycle: pyrrole<br><br>Indication: treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy<br><br>Target: RANKL (RANK ligand), a protein that acts as the primary signal to promote bone removal/resorption.<br><br>MOA: Inhibits RANKL and helps regulate turnover in healthy bone. Denosumab binds with high specificity and affinity to the cytokine RANKL, inhibiting its action; as a result, osteoclast recruitment, maturation and action are inhibited, and bone resorption slows<br><br>Role: Antagonist<br><br>Side Effects:</div><ul><li>red, dry, or itchy skin</li><li>oozing or crusty blisters on skin</li><li>peeling skin</li><li>back pain</li><li>pain in your arms</li><li>swelling of arms or legs</li><li>muscle or joint pain</li><li>nausea</li></ul>]]></description>
         <enclosure url="http://ar.iiarjournals.org/content/33/5/1793/F3.large.jpg" />
         <pubDate>2022-10-03 04:24:52 UTC</pubDate>
         <guid>https://padlet.com/hoangle/ale/wish/2323142728</guid>
      </item>
   </channel>
</rss>
